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Skeletal muscle disuse atrophy is a debilitating medical condition that occurs as 
result of limb immobilization and whole body bed rest. Severe reductions to muscle 
mass contribute to functional declines, disability, and metabolic comorbidities, such as 
obesity, Type II diabetes, and cardiovascular disease. Physical rehabilitation is the most 
commonly prescribed therapy to help recover from disuse atrophy; however, illness and 
lack of mobility may limit physical activity and full recovery may not be possible, 
particularly in older adults. Therefore, there is a need to develop novel and more 
effective rehabilitation strategies.   
Satellite cells are myogenic progenitor cells that render muscle capable of repair 
and regeneration, yet the role for these cells in fiber growth and restoration of function 
following disuse is equivocal. Perivascular stem/stromal cells, including pericytes, reside 
in close proximity to microvessels, possess myogenic capacity, and secrete various 
regenerative paracrine factors, making them ideal candidates for stem cell-based 
therapies. However, minimal information exists regarding their response to periods of 
disuse or their contribution to muscle recovery upon a return to physical activity. Thus, 
the purpose of this study was to 1) determine the impact of immobilization and 
remobilization on pericyte quantity and function, and 2) determine the ability for 
exogenously administered pericytes to improve recovery following disuse.  
 Utilizing a unilateral hindlimb immobilization model that results in specific atrophy 
of the tibialis anterior (TA) muscle, relative pericyte content was quantified by multiplex 
flow cytometry immediately following 14 days of immobilization and following 14 days of 
remobilization post-disuse. NG2+CD31-CD45- and CD146+CD31-CD45- pericytes were 
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collected using fluorescence-activated cell sorting (FACS) following the remobilization 
period, and gene expression was analyzed as a readout of functionality. Finally, both 
pericyte populations were loaded into a biodegradable, low molecular weight RGD-
alginate hydrogel and transplanted into atrophied TA muscles prior to remobilization. 
We observed significant reductions to pericyte quantity with immobilization that was 
recovered with remobilization. However, pericyte gene expression patterns were not 
markedly altered at the end of the remobilization period. Interestingly, pericyte 
transplantation immediately prior to remobilization resulted in significant recovery of 
myofiber size and muscle capillarization. 
 The data from these experiments suggest that pericytes are reduced following a 
period of disuse, and importantly, pericyte transplantation improved skeletal muscle 
recovery when introduced immediately prior to remobilization. These novel findings 
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 Skeletal muscle comprises approximately 40% of human body mass and 
contains between 50-75% of whole body protein. As such, muscle tissue is responsible 
for a host of vital functions, including movement, force production, thermoregulation, 
substrate storage and usage, and growth factor and cytokine production (Frontera and 
Ochala, 2015). Skeletal muscle is a highly plastic tissue, and external stimuli, such as 
exercise or physical inactivity, have considerable influence on the anatomy and 
physiology of muscle (Degens and Alway, 2006; McGlory and Phillips, 2015). Both 
resistance and endurance exercise training facilitates beneficial adaptations to muscle 
mass, strength, and metabolism, while periods of inactivity lead to dramatic losses to 
muscle size (atrophy) and function resulting in severe health impairments. Thus, 
preventing or reversing muscle loss due to inactivity is critical to maintaining a high 
quality of life. 
 
1.1 Significance  
 Skeletal muscle disuse atrophy is a debilitating medical condition caused by 
muscular unloading and physical inactivity commonly observed during joint 
immobilization, bed rest, denervation, and microgravity (Bodine, 2013; Brooks and 
Myburgh, 2014; Narici and de Boer, 2011). The main consequence of disuse is severe 
reductions to skeletal muscle mass and strength as well as overall dysfunction to 
muscle physiology. Disuse-mediated alterations to skeletal muscle result in an 
increased incidence of comorbidities, such as cardiovascular disease (CVD), obesity, 
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insulin resistance, Type II diabetes, hypertension, endothelial dysfunction, and in some 
cases, mortality (Atherton et al., 2016; Boyle et al., 2013; Farrar et al., 2013).  However, 
periods of inactivity may be required for individuals recovering from a physical injury or 
illness in order for proper healing to occur. Unfortunately, even transient periods of 
physical unloading results in significant, measureable losses to skeletal muscle mass 
and strength, which is further exacerbated by age (English and Paddon-Jones, 2010; 
Wall et al., 2013).  
 The Department of Health and Human Services Administration on Aging 
estimates that approximately 72 million individuals (~20% of the United States 
population) will be older than 65 years of age by 2030 (Administration on Aging, 2017). 
Concomitant with age is an increased risk of hospitalization attributable to illness or 
physical injury, which requires reduced levels of physical activity that combined results 
in substantial skeletal muscle loss (Ferrando, 2000; Fisher et al., 2010). This loss 
begins rapidly (<7 days) and can persist even with structured physical rehabilitation. 
This is particularly relevant for the treatment of older individuals, as mobility may be 
limited and the mechanical load insufficient to fully stimulate muscle growth (Hvid et al., 
2010; Suetta et al., 2013). Due to the rapid and substantial muscle loss observed with 
disuse as well as the concurrent risk of developing harmful comorbidities, there is a 
pressing need for research on how to effectively treat and rehabilitate individuals 
suffering from disuse atrophy. Regrettably, there are no reliable medical therapies 
(pharmacological or otherwise) currently available to improve skeletal muscle recovery 
after disuse. 
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 Over the past 50 years, mesenchymal stem/stromal cell (MSC) transplantation 
has been extensively studied as a therapeutic option for the treatment of a wide range 
of diseases and medical disorders. Utilizing both human and animal models as well as 
various tissue sources, MSC transplantation has demonstrated beneficial results in the 
treatment of CVD, liver cirrhosis, spinal cord injury, cartilage and bone injury, muscular 
dystrophy, wound healing, rheumatoid arthritis, lung disease (e.g. COPD, asthma), 
neurological disorders (e.g. amyotrophic lateral sclerosis (ALS), multiple sclerosis 
(MS)), and sepsis, among others (Caplan and Correa, 2011; García-Castro et al., 2008; 
Squillaro et al., 2016). Within skeletal muscle, various cell populations have been 
identified that demonstrate a capacity for multi-lineage differentiation and express 
markers consistent with MSCs, but are not defined as “MSCs” given the more rigorous 
requirements for appropriate MSC classification (Boppart et al., 2013; Dominici et al., 
2008). Pericytes are one example of a muscle-resident mononuclear cell with multi-
lineage potential. 
 Pericytes are perivascular stem/stromal cells residing adjacent to the endothelial 
cells of microvessels and capillaries, providing vital structural and paracrine support to 
regulate blood flow and local angiogenesis (Armulik et al., 2011). Studies suggest that 
perivascular stem/stromal cells synthesize and release regenerative factors in response 
to a variety of stimuli that can beneficially influence myofiber size and strength (Díaz-
Flores et al., 2009; Huntsman et al., 2013; Zou et al., 2015). However, there is a 
significant gap in knowledge regarding the extent to which pericytes specifically 
contribute to the skeletal muscle recovery process during rehabilitation post-disuse. The 
long-term goal of this research is to identify novel therapeutic targets for the treatment 
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and management of skeletal muscle disuse atrophy. The main objectives of this 
research project include the following: (1) to elucidate the pericyte response to hindlimb 
immobilization and remobilization, and (2) to determine the efficacy of a pericyte 
transplantation therapy to improve skeletal muscle recovery post-immobilization. The 
specific aims below will address these objectives. 
 
1.2 Specific Aims 
Specific Aim 1: To determine the pericyte response to hindlimb immobilization-
induced skeletal muscle atrophy and recovery in adult mice.  
 The goal of this aim is to test the hypothesis that hindlimb immobilization results 
in significant alterations to pericyte (NG2+CD31-CD45- (Lin-) and CD146+Lin-) quantity 
and function in adult, male C57BL/6 mice. Our laboratory and others have effectively 
demonstrated the responsiveness of perivascular stem/stromal cells to strain, exercise, 
and diet (De Lisio et al., 2014; Huntsman et al., 2013; Pincu et al., 2016). Specifically, 
pericytes appear sensitive to disruptions to their local microenvironment (from either 
age or injury) (Munroe et al., 2017; Zou et al., 2015). Thus, pericytes are likely to be 
responsive to hindlimb immobilization and remobilization given the tissue remodeling 
that occurs during unloading (McClung et al., 2006; Urso et al., 2006).  
 In order to ascertain the pericyte response to disuse atrophy and recovery, a 
unique hindlimb immobilization model will be used to induce atrophy of the tibialis 
anterior (TA) muscle (Caron et al., 2009). This model involves the pinning of the mouse 
foot in full dorsiflexion, maintaining the TA in a shortened position for the duration of the 
experiment resulting in significant muscle atrophy. Utilizing multiplex flow cytometry, 
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pericyte quantity will be evaluated following two weeks of hindlimb immobilization with 
or without two weeks of remobilization. Finally, gene expression analysis will be 
completed to assess pericyte function on cells isolated by fluorescence-activated cell 
sorting (FACS) post-remobilization.  
We hypothesize that hindlimb immobilization will significantly decrease pericyte 
quantity concurrent with skeletal muscle loss. In addition, pericyte gene expression will 
be negatively impacted by disuse in a manner that will be reflected at the end of the 
remobilization period. Alternatively, pericyte quantity and function may not be altered as 
a result of immobilization and remobilization. If observed, this would indicate that 
pericyte quantity is unaffected by immobilization or that pericyte stability is necessary to 
counter loss of muscle during disuse. Gene expression patterns can rapidly change in a 
temporal manner. Thus, if no change in gene expression is observed at the end of the 
remobilization period (2 weeks following 2 weeks of immobilization), future follow up 
assessments may be necessary at earlier time points.  
 
Specific Aim 2: To determine the efficacy of a pericyte transplantation therapy on 
skeletal muscle recovery following immobilization. 
 The goal of this aim is to test the hypothesis that pericyte transplantation prior to 
hindlimb remobilization will significantly enhance skeletal muscle recovery after 
immobilization. As stem cell therapy is an important clinical tool used to combat a host 
of medical conditions (Giordano et al., 2007), optimizing the transplantation 
methodology is vital. Consistent issues with standard transplantation methods include 
poor cell viability and survival post-transplantation. Interestingly, the use of scaffolds 
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and hydrogels as transport vehicles for stem cells have demonstrated improved 
transplantation efficiency and cell viability (Panda et al., 2014; Schulze and Tobiasch, 
2012).  
 To address this hypothesis, pericytes (NG2+Lin- and CD146+Lin-) will be isolated 
from murine skeletal muscle by FACS and loaded into a low molecular weight, 
biodegradable, RGD-alginate hydrogel together (Kong et al., 2003), which will then be 
transplanted into atrophied TA of adult, male C57BL/6 mice, immediately prior to 
remobilization. NG2+Lin- and CD146+Lin- pericytes will be isolated separately by FACS 
as in Specific Aim 1 and cultured for ten days to allow for recovery and expansion. 
Immediately prior to combining and injecting into muscle, both pericyte types will be 
transfected with either a CMV-driven ZsGreen or tdTomato fluorescent protein vectors 
to determine the pericyte-specific fate post-transplantation. Skeletal muscle recovery 
will be determined histologically by analyzing differences in myofiber cross sectional 
area, pericyte localization, capillary quantity, inflammation, and collagen accumulation.  
We hypothesize that pericytes encapsulated into a low molecular weight RGD-
alginate hydrogel will improve muscle recovery and growth following hindlimb 
immobilization. Alternatively, a lack of enhancement will indicate that pericytes do not 
improve the muscle recovery process following a period of disuse. 
 
1.3 Summary 
 The major goal of this work is to guide researchers and clinicians toward the 
development of pericyte-related therapies designed to enhance the recovery of 
atrophied skeletal muscle. This will be accomplished by (1) assessing pericyte quantity 
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and function during and after immobilization using hindlimb immobilization, and by (2) 
determining the efficacy of a pericyte transplantation to improve skeletal muscle 
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 Skeletal muscle mass (atrophy) and strength may decline as a result of a wide 
variety of medical conditions. Disease- and injury-related muscle wasting is frequently 
observed clinically in patients suffering from cancer, metabolic disorders, burn wounds, 
respiratory diseases, and sepsis (Kalantar-Zadeh et al., 2013). This systemic and 
inflammatory form of disease-mediated, severe muscle loss (cachexia) is an ill-fated 
prognostic marker (Malavaki et al., 2015). Cachexia exacerbates disease symptoms 
leading to an increased occurrence of dangerous comorbidities, and at times, premature 
mortality (Bonaldo and Sandri, 2013; Kalantar-Zadeh et al., 2013).  
In addition to the atrophy directly linked to illness and inflammation, muscle loss 
may also occur as a result of reduced levels of physical activity during bed rest. Disuse 
atrophy is experienced by skeletal muscle undergoing reduced physical loading and 
decreased neuronal stimulation (Atherton et al., 2016; Bodine, 2013). Disuse is most 
frequently experienced in individuals undergoing bed rest, limb or joint immobilization, 
denervation post-spinal cord injury, and in those exposed to microgravity (Adams et al., 
2003; Cho et al., 2016). Despite the interaction between disease-mediated atrophy and 
disuse atrophy, disuse atrophy is a distinct medical condition. Even in the absence of 
disease, sedentary behavior leads to progressive and insidious muscle atrophy. As 
approximately 30% of adults fail to meet governmental physical activity guidelines, there 
is a substantial percentage of the otherwise healthy world population living a sedentary 
lifestyle (Hallal et al., 2012). Understanding the factors and consequences underlying 
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disuse atrophy, and what treatments can be implemented to ameliorate it, is essential to 
improve the clinical outcomes of individuals suffering from muscle atrophy. 
 
2.2 Disuse Atrophy 
Impact of Disuse on Skeletal Muscle Mass and Microstructure 
 Skeletal muscle atrophy is highly dependent on both the manner and severity of 
physical inactivity or disuse. Depending on how disuse or physical unloading occurs, 
skeletal muscle can be selectively and differential affected. Various models of inactivity 
and unloading have been utilized to investigate how skeletal muscle responds to disuse 
(Cho et al., 2016). The three main ground-based models of disuse are bed rest, limb 
immobilization, and limb suspension (Adams et al., 2003). Each model results in similar 
physiological and functional changes to muscle. For each model, the most significant 
complication is a reduction in muscle mass and size (Baldwin, 2013). Which muscles 
and the magnitude of loss, however, are not necessarily uniform. Multiple studies have 
demonstrated significant reductions to muscle size and mass following both short-term 
(Cros et al., 1999; Fox et al., 2014; Gallegly et al., 2004; Suetta et al., 2013; Thom et 
al., 2001; Wall et al., 2016) and prolonged (Baehr et al., 2016; Deitrick, 1948; Ferrando 
et al., 2010; Hvid et al., 2010; Jackson et al., 2012; LeBlanc et al., 1992; Paddon-Jones 
et al., 2004; Trappe et al., 2007) disuse, regardless of model system, using a multitude 
of measurement techniques (i.e. MRI, DEXA, anthropometric measures, 
ultrasonography, CT) (Adams et al., 2003; Kortebein et al., 2007; LeBlanc et al., 1995; 
Thom et al., 2001). Interestingly, disuse atrophy appears to affect select muscle groups 
preferentially, particularly the postural/antigravity muscles of the lower limb (Fitts et al., 
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2000). Specifically, the extensor muscles of the calf (soleus, medial gastrocnemius) and 
quadriceps (vastus lateralis) exhibit substantial size and volume loss compared to the 
flexor muscles (tibialis anterior and extensor digitorum longus) (Bodine, 2013; Ohira et 
al., 2006; Phillips et al., 2009). These findings appear in both human and rodent 
models, although much more variability exists within human subjects due to larger 
individual differences in muscle size and composition pre-inactivity (Clark, 2009; Fitts et 
al., 2000; Rennie et al., 2010). In comparison to conditions of whole body disuse, both 
limb immobilization and limb suspension result in targeted muscle atrophy. Atrophy in 
these conditions is only observed in those muscle group(s) undergoing disuse. Lower 
limb joint immobilization via casting or pinning exhibits more significant atrophy if fixed 
in a shortened versus a lengthened or neutral position (Slimani et al., 2012; Spector et 
al., 1982). Similarly, unilateral lower limb suspension (ULLS) consistently demonstrates 
significant muscle size reductions in humans (Berg and Tesch, 1996), which is equally 
observed in rodents undergoing hindlimb suspension (HLS) (Morey-Holton and Globus, 
2002; Wronski and Morey-Holton, 1987; Fluckey et al., 2004).  Muscle loss occurs 
rapidly regardless of model, especially in rodents. Within the first 1-2 weeks of disuse, 
rapid muscle weight loss is observed which then slows and decreases minimally 
throughout the duration of disuse (Bodine, 2013; Wall et al., 2013).  
 At the myofiber level, specific patterns of fiber type atrophy are frequently 
observed regardless of species or model (Brocca et al., 2012; Thomason et al., 1992). 
In general, the progression of atrophy in young, healthy muscle occurs most rapidly and 
severely first in the slow-twitch Type I (oxidative) fibers, then the fast-twitch Type IIa 
(oxidative) fibers, followed by the fast-twitch Type IIx and IIb (glycolytic) fibers (Baldwin, 
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2013; Trappe et al., 2004). As the extensor muscles are primarily comprised of Type I 
and IIa fibers, these muscle groups correspondingly atrophy first while the flexor 
muscles, which contain a larger percentage of Type IIx/b fibers (especially in rodents), 
are more resistant and atrophy second (Fitts et al., 2000; Thomason and Booth, 1990). 
These particular muscle groups have distinct fiber type composition (i.e. myosin heavy 
chain (MHC) isoform expression) reflecting the selective fiber type atrophy progression. 
However, at least in human subjects, these fiber type responses to disuse are not 
always observed. While most rodent studies observe homogeneous and significant 
losses to specific myofiber types size (i.e., Type I > Type II fibers), human studies have 
been more variable (Hvid et al., 2010; Phillips et al., 2009; Trappe et al., 2008). Certain 
studies have reported that myofiber atrophy is heterogeneous across the muscle and 
that specific types are not always differently affected (Psatha et al., 2012), which could 
be attributable to muscle group analyzed (vastus lateralis versus soleus) and the 
anatomical location where the tissue is collected (Bodine, 2013; Rennie et al., 2010). In 
addition to alterations to myofiber size within atrophying muscles, muscle fiber type 
composition is also affected. Myofiber composition not only shows size reductions, but 
also fiber type transition from slow to fast twitch fibers. With disuse of predominantly 
slow twitch muscles (e.g. soleus) a significant increase in the occurrence of hybrid 
myofibers (fibers expressing both MHC I and MHC II isoforms) exists. Specifically, 
Trappe et al. (2004) observed that post-bed rest, the percentage of MHC I fibers was 
significantly reduced from 64% to 35% within the vastus lateralis while the percentage 
of fibers expressing MHC I/IIa/IIx increased from 0% to 16% (Trappe et al., 2004). 
Similarly, Ohira et al. (1992) had previously observed that in the soleus muscle of rats 
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post-14 days of spaceflight, there was an increase in the percentage of myofibers 
expressing both slow and fast MHC (0% to 16%) (Ohira et al., 1992). Overall, multiple 
studies have demonstrated comparable findings of increased fast twitch MHC 
expression in slow twitch myofibers post-disuse (Fitts et al., 2000).  
 One major complication in understanding disuse atrophy is the important species 
differences observed between rodents and humans. The magnitude and rate of rodent 
muscle loss following inactivity is much greater than that in humans. In general, human 
muscle loss with disuse is approximately 0.5% total muscle mass per day (Wall and van 
Loon, 2013) while in rodents (depending on the muscle group analyzed) that muscle 
loss can range from ~1.5-3.0%/day (Phillips et al., 2009). This significant difference in 
the rate of atrophy is also reflected at the microstructure level with alterations to 
myofiber type CSA being more extreme in rodents compared to humans Human 
myofiber CSA reductions are much more homogenous between Type I and Type II 
myofibers compared to rodents, which are more frequently observed in Type I fibers 
(Rennie et al., 2010; Phillips et al., 2009). Despite these species differences, the 
scientific literature demonstrates that the various disuse models employed to study 
atrophy result in significant muscle loss, with a majority of studies suggesting 
preferential loss within the extensor muscles and more specifically, within Type I 
myofibers. 
Functional Changes to Atrophied Skeletal Muscle Post-Disuse 
 Concomitant with reductions to skeletal muscle size and mass following both 
acute and prolonged disuse are significant detriments to muscle strength, force 
production, and fatigue resistance. These reductions, like the reductions to muscle 
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mass and size, are dependent on the severity and duration of muscle disuse. In 
general, limb immobilization results in a significantly greater percent loss to voluntary 
strength followed by bed rest then lower limb suspension (Clark, 2009). Interestingly, 
the severity of strength loss far exceeds the accompanying muscle atrophy early on in 
the disuse period (upwards of ~4% strength loss per day) (Thom et al., 2001; Wall and 
van Loon, 2013) suggesting that other neuromuscular complications contribute to 
muscle loss with physical inactivity (Clark et al., 2009; Deschenes et al., 2002). Deficits 
in central nervous system activation as well as disruptions to excitation-contraction 
uncoupling function are significant neurological issues contributing to the severe 
reduction to voluntary muscle force production and motor control early on in the disuse 
period (Clarke et al., 2006; Clark and Manini, 2008). Subsequently, disruptions to 
skeletal muscle contractile proteins and intrinsic myofiber properties reduce force 
production and muscle strength thereafter. Specifically, disuse-mediated reductions in 
individual myofiber peak force production and power production in both Type I and II 
fibers are observed after both spaceflight and bed rest (Fitts et al., 2000; Hvid et al., 
2013; Trappe et al., 2004; Trappe et al., 2008). While shortening velocity does increase 
in these instances, possibly due to the relative increase in Type II/fast twitch MHC 
expression, this increase is unable to compensate for the losses to overall myofiber 
force and power production (Trappe et al., 2008). The combination of both neurological 
and skeletal muscle contractile dysfunction appears to be responsible for the severe 
strength reductions observed in the atrophied muscles early on in the disuse period. 
Vascularization Changes with Disuse  
	17	
 Vascularization and blood flow regulation are vital to the overall health and 
function of skeletal muscle. Vascularization is a highly regulated and adaptable process 
with improved angiogenesis, blood flow, and capillarization occurring with increased 
physical activity (Haas and Nwadozi, 2015; Latroche et al., 2015). In contrast, the 
significantly impaired vascularization observed during peripheral artery disease (PAD) 
and various metabolic conditions (e.g. Type II diabetes) results in muscle ischemia, 
intermittent claudication, and possibly, tissue necrosis (Criqui and Aboyans, 2015; 
Goodwill and Frisbee, 2012). Similarly, periods of physical inactivity have been 
observed to induce significant alterations to various aspects of skeletal muscle 
vascularization (Thijssen et al., 2010).   
 The capillary bed is the primary site of nutrient and gas exchange throughout the 
body, and is vital to the maintenance of skeletal muscle health (Latroche et al., 2015). 
As such, alterations to muscle microvasculature appear to occur primarily at the level of 
the capillaries during disuse (Tyml and Mathieu-Costello, 2001). Even brief periods of 
inactivity can result in significant microvasculature dysfunction. Hamburg et al. (2007) 
observed reduced reactive hyperemia in both upper and lower extremities following 5 
days bed rest concurrent with the development of insulin resistance in otherwise healthy 
individuals similar to previous findings utilizing longer disuse periods (Hamburg et al., 
2007; Shoemaker et al., 1998). Additionally, disuse can result in detrimental alterations 
to capillary content and structure (Tyml and Mathieu-Costello, 2001).  Significant 
reductions to capillary number (capillary-to-fiber ratio; C/F ratio) and/or capillary density 
(capillary/mm2 tissue) have frequently been observed in multiple model systems, with 
more pronounced changes observed in oxidative/Type I myofibers reflecting the fiber 
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type specificity of disuse atrophy (Józsa et al., 1980; Kaneguchi et al., 2014; Kano et al., 
2000; Rudnick et al., 2004; Roudier et al., 2010). However, some studies have 
observed little to no change to capillarization following bed rest (Bosutti et al., 2016; 
Dirks et al., 2016). Like the variable changes in the magnitude of atrophy following 
disuse, these discrepancies in capillarization could be attributable to differences in 
model system and species used between studies. Morphologically, several studies have 
observed disruptions to capillary structure, which do not necessarily correlate with 
alterations to the C/F ratio or capillary density (Tyml and Mathieu-Costello, 2001). 
Increased capillary degeneration, fenestration/pores, and endothelial damage result in 
microvascular dysfunction in both humans and animals following periods of inactivity 
(Carpenter and Kapati, 1982; Oki et al., 1996; Tyml et al., 1995; Tyml et al., 1999). 
Overall, it appears that disruptions to capillarization content and structure are evident in 
atrophying muscle, possibly contributing to fiber size and strength reductions. 
 
2.3 Mechanisms Underlying Disuse Atrophy 
Muscle Protein Balance Disruptions 
 Muscle mass is maintained through a balance between muscle protein synthesis 
(MPS) and muscle protein breakdown (MPB). This balance of the sinusoidal fluctuations 
in synthesis and breakdown over twenty-four hours determines whether an individual 
will be in state of net protein anabolism or catabolism per day (Gorissen et al., 2015). 
Muscle protein balance is highly responsive to both feeding and physical activity with 
increased MPS being observed immediately post-feeding and an overall net increase in 
synthesis post-exercise (upwards of 24 hours) (Burd et al., 2011; Burd et al., 2013; 
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Morton et al., 2018). In contrast, muscle protein balance is negatively impacted by 
physical inactivity and muscular disuse resulting in reduced MPS and increased MPB, 
yielding a net catabolic state (Anthony, 2016; Rudrappa et al., 2016). However, debate 
exists regarding whether the reduction to MPS or the increase in MBP is the main 
contributor to muscle loss during periods of disuse (Atherton et al., 2016; Bodine et al., 
2013; Phillips et al., 2009). In human studies, consistent reductions to resting MPS are 
observed with acute measurements suggesting ~40-50% decline in daily MPS with 
disuse (Atherton et al., 2016). Some authors have suggested that these reductions to 
MPS are solely responsible for the observed muscle mass loss with disuse (Phillips et 
al., 2009; Rennie et al., 2010) although the underlying mechanism remains unclear. A 
reduction to mammalian target of rapamycin (mTOR) activation has been suggested as 
a driving factor in the decrease to MPS with disuse. Decreased phosphorylation of key 
protein synthesis regulators, Akt, mTOR, and p70S6K, has been observed following 
immobilization and hindlimb unloading (Bodine et al., 2001; Drummond et al., 2012; 
Kelleher et al., 2015). However, in human studies these alterations to Akt/mTOR 
signaling are not consistently present (de Boer et al., 2007; Marimuthu et al., 2011; Wall 
et al., 2013). Despite these inconsistencies, reductions to protein translation initiation 
and ribosomal biogenesis have been implicated as one of the main factors involved in 
the decrease to MPS (Hornberger et al., 2001; von Walden et al., 2012).  
 Transient, but significant, increases to MPB are likely to have an important role in 
muscle loss, especially in the first few days of disuse. Unfortunately, direct 
measurements of MPB are difficult to obtain in human subjects (Holm and Kjaer, 2010), 
and thus, primary data regarding protein breakdown is based off of indirect markers and 
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factors associated with protein degradation pathways. Expression of key ubiquitin 
proteosome pathway (UPP) E3 ligases, Muscle Atrophy F-box (MAFbx)/Atrogin-1 and 
Muscle Ring Finger 1 (MuRF-1), are rapidly and transiently upregulated following 
unloading, corresponding to the early key window of muscle mass loss in both humans 
and rodents (Bodine and Baehr, 2014; Glover et al., 2010; Murton et al., 2008).  These 
two E3 ligases are heavily involved in the degradation of proteins that are part of the 
protein-synthetic machinery within skeletal muscle (Bonaldo and Sandri, 2011). A 
decrease in the phosphorylation of the Forkhead box O (FoxO) transcription factors, 
FoxO1 and FoxO3a, results in increased transcription of these E3 ligases, leading to 
enhanced protein degradation. The increases in MPB may be mediated by disruptions 
to components of the protein synthetic machinery as well as myofibrillar protein content 
via E3 expression, as these ligases are responsible for the degradation of MyoD, eIF3f, 
troponin, and MHC proteins (Bonaldo and Sandri, 2013; Ogawa et al., 2006; Phillips et 
al., 2009). Despite the prominent role the UPP ligases have in regulating muscle 
atrophy, a host of other factors are highly expressed during disuse (Stevenson et al., 
2003). Activating transcription factor 4 (ATF4) and p53 have been implicated as 
significant contributors to the atrophic process in multiple disuse models, including 
starvation, immobilization, and denervation (Ebert et al., 2010; Ebert et al., 2015; Fox et 
al., 2014). Interestingly, mice lacking both ATF4 and p53 expression exhibited strong 
resistance to skeletal muscle loss in a variety of atrophic conditions (Fox et al., 2014). 
However, the precise interaction between MPS and MPB during disuse atrophy remains 
to be fully elucidated. 
Skeletal Muscle Stem/Stromal Mononuclear Cells  
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 The role of muscle-resident stem/stromal cells in the recovery process post-injury 
has been increasingly studied. The primary progenitor cell studied has been the satellite 
cell (Pax7+; SC) (Dumont et al., 2015; Sambasivan et al., 2011). In response to injury 
and myotrauma, SCs begin to proliferate and co-express myogenic regulatory factors 
(MRFs), including MyoD and Myf5 (Brooks and Myburgh, 2014; Yin et al., 2013). These 
proliferating cells either continue expressing MRFs (MyoD and myogenin) and 
differentiate into a myoblast, or retain Pax7 expression and return to a quiescent 
(undifferentiated) state (Hawke and Gary, 2001). Myoblasts can then fuse with 
damaged myofibers to allow for repair or fuse with other myoblasts to form a new 
myofiber (Goh and Millay, 2017; Relaix and Zammit, 2012; Yin et al., 2013). The role for 
the SC in repair of skeletal muscle injury is well acknowledged (Günther et al., 2013; 
Lepper et al., 2011; Sambasivan et al., 2011), but the extent to which these cells 
influence growth in response to loading or unloading is controversial (Murach et al., 
2018). Select research has demonstrated that myofiber hypertrophy in response to 
chronic overload requires direct SC involvement (Egner et al., 2016; Goh and Millay, 
2017), however, others have observed significant muscle growth even in the absence of 
SCs (Fry et al., 2014; McCarthy et al., 2011; Murach et al., 2017). Investigations into the 
SC response to atrophy and contribution to muscle recovery post-disuse have also 
yielded conflicting results. SC content and proliferation appears to be species-, model-, 
and duration-dependent, with decreases (Arentson-Lantz et al., 2016; Darr and Schultz, 
1989), increases (Alway et al., 2013; Brooks et al., 2018; Liu et al., 2015; Suetta et al., 
2013), or no changes (Brooks et al., 2009; Jackson et al., 2012; Snijders et al., 2014) to 
total SC quantity observed during atrophy. Importantly, SCs appear to have a limited 
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(Itoh et al., 2014) to non-existent role (Jackson et al., 2012) in the recovery process 
following disuse. Previous work has observed that the targeted depletion of SCs prior to 
hindlimb suspension resulted in no difference to muscle weight, myofiber cross 
sectional area (CSA), or single myofiber force production after reload (Jackson et al., 
2012). Overall, these findings suggest that SCs are not integral components to the 
recovery process post-disuse. This raises the possibility that other skeletal muscle 
mononuclear progenitor cells are significant contributors to muscle regrowth in a SC-
independent manner, particularly in mature muscle (Boppart et al., 2013; Murach et al., 
2018). 
 
2.4 Skeletal Muscle Pericytes 
 Pericytes, a population of contractile cells surrounding small blood vessels, were 
first described in the early 1870s (Rouget, 1873). In 1923, Zimmerman coined the term 
“pericyte” due to their close proximity to endothelial cells (Armulik et al., 2011). 
Currently, pericytes are defined as contractile cells physically embedded within the 
vascular basement membrane of microvessels, specifically around capillaries and post-
capillary venules (Attwell et al., 2016; Caplan and Correa, 2011; Sims, 1986). Pericyte 
cytoplasmic processes usually span and enwrap multiple endothelial cells, but unlike 
other periendothelial cell populations, such as vascular smooth muscle cells (vSMCs), 
pericytes are in direct, intimate contact with endothelial cells via peg-socket contacts, 
gap junctions, and adhesion plaques (Armulik et al., 2005; Díaz-Flores et al., 2009). 
Given the wide range of vascularization present in different tissue types, pericyte 
abundance is highly variable. Pericyte to endothelial cell coverage within skeletal 
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muscle is estimated to be between 1:10 and 1:100 (Armulik et al., 2011). Pericyte 
morphology and abundance allows for a wide range of functions in the regulation of 
vascularization and tissue maintenance. However, no one pericyte-specific molecular 
marker has been discovered which could be linked unambiguously to all pericytes within 
all tissue types. Thus, different markers have to be utilized in order to identify pericytes, 
including alkaline phosphatase (ALP/AP), alpha-smooth muscle actin (α-SMA), desmin, 
and PDGF receptor-beta (PDGFR-β) (Armulik et al., 2011; Dellavalle et al., 2011; 
Gerhardt and Betsholtz 2003). Within skeletal muscle, two markers have frequently 
been used to identify pericytes: melanoma cell adhesion molecule (Mcam; CD146) 
(Crisan et al., 2008; Sacchetti et al., 2016) and chondroitin sulfate proteoglycan, neural-
glial antigen 2 (Cspg4; NG2) (Birbrair et al., 2013). It appears that a high percentage of 
cells expressing either or both markers, and lacking expression of markers specifically 
related to other cell types such as endothelial (CD31, CD34) and immune (CD45) 
lineages, are closely associated with a traditional pericyte-phenotype. Thus, these 
markers are highly useful in the identification and characterization of pericytes, 
especially within skeletal muscle. 
 The primary functions of pericytes include microvessel stabilization and the 
regulation of vessel contractility, angiogenesis, and capillary sprouting (Díaz-Flores et 
al., 2009). Vessel stabilization and contractility are influenced by pericyte morphology 
and architecture. Being localized and in direct contact with endothelial cells help 
pericytes to regulate the balance between microvessel vasoconstriction and 
vasodilation (Armulik et al., 2005; Nakano et al., 2000). Angiogenesis is a highly 
complex, multi-step process that is mediated in part by pericyte activity. Pericytes must 
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detach and assist in the degradation of the local basement membrane before 
angiogenesis can begin (Díaz-Flores et al., 1992). Once vascular sprouting and 
maturation has been completed, pericytes must proliferate and migrate to new capillary 
branches in order to re-stabilize the new microvessels (Díaz-Flores et al., 2009). In 
order to complete all of these functions, pericytes synthesize and secrete various 
extracellular matrix (ECM) remodeling proteins and growth factors into the local 
microenvironment. Matrix metalloproteinases (MMP-2, MMP-9) and plasminogen 
activator inhibitors (PAI1) are released in order to degrade the surrounding basement 
membrane, facilitating pericyte dissociation from the original microvessel in the initial 
stages of angiogenesis  (Virgintino et al., 2008). Subsequent secretion of fibroblast 
growth factor 2 (FGF2), platelet-derived growth factor (PDGF), and vascular endothelial 
growth factor (VEGF) initiate pericyte migration and proliferation (Watanabe et al., 1997; 
Yamagishi et al., 1999). Upon the angiopoietin-2 induction of vessel maturation 
(Nishishita and Lin, 2004), transforming growth factor-beta (TGF-β) helps form the ECM 
around newly formed vessel, and sphingosine-1-phosphate (S1P) causes cytoskeletal 
adhesion of pericytes to endothelial cells (Paik et al., 2004). Thus, pericytes are vital for 
not only the stability and contractility of microvessels, but also the growth and 
maturation of newly formed microvessels.   
 One important characteristic of pericytes, and in particular those derived from 
skeletal muscle, is their mesenchymal stem cell-like characteristics both in vitro and in 
vivo. It has been postulated that SCs are not the only important myogenic progenitor 
within skeletal muscle, so research in the past decade has also focused on the 
possibility of MSCs/pericytes to contribute to de novo myogenesis (Crisan et al., 2008; 
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Dellavalle et al., 2007; Dellavalle et al., 2011). Various laboratories have demonstrated 
a robust capacity for muscle-derived, non-SC progenitor cells (expressing CD146, NG2, 
or both) to differentiate into new myofibers in culture (Birbrair et al., 2013; Sacchetti et 
al., 2016). Interestingly, this myogenic capacity can be maintained upon transplantation 
into injured skeletal muscle. Both Dellavalle et al. (2007) and Crisan et al. (2008) 
demonstrated that injection of human-derived perivascular stem cells (ALP+ or CD146+ 
cells lacking expressing of CD31/CD34/CD45/CD56) into injured or dystrophic muscle 
resulted in direct engraftment into developing myofibers (Crisan et al., 2008; Dellavalle 
et al., 2007). Meanwhile, Sacchetti et al. (2016) observed not only engraftment of 
muscle-derived perivascular progenitor cells into myofibers of mice recovering from 
cardiotoxin injury, but also localization within the interstitum between fibers. 
Surprisingly, these cells also appeared beneath the basement membrane around 
myofibers in a satellite-cell position as well as expressing CD56 and Pax7 suggesting 
that these stem cells could give rise to satellite cells (Sacchetti et al., 2016). 
Additionally, these perivascular stem cells were previously demonstrated to behave like 
SCs in different in vitro and in vivo assays (Montarras et al., 2005). As such, these 
findings suggest that perivascular stem cells expressing CD146 (i.e. pericytes) 
represent a non-SC population that can function in a quintessential myogenic progenitor 
manner. Other laboratories have focused more on the capacity for another distinct 
pericyte population expressing NG2 to support myogenesis and skeletal muscle 
regrowth following injury. The Delbono laboratory has observed a specific population of 
NG2+Nestin+ cells (expressing two other pericyte markers, CD146 and PDGFRβ) is 
highly myogenic in culture, and upon transplantation into barium chloride injured muscle 
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(Birbrair et al., 2013). Overall, it appears that pericytes are capable of enhancing muscle 
recovery post-injury; however, their contribution to muscle regrowth following disuse 
atrophy remains unexplored. 
 
2.5 Therapeutic Strategies to Treat Disuse Atrophy 
 Current treatment options to reverse or at least attenuate the muscle loss seen 
with disuse are primarily resistance exercise/rehabilitation programs and/or nutritional 
interventions (Mallinson and Murton, 2013; Stein and Blanc, 2011). Given the reduction 
to fasted state MPS rates during periods of inactivity and unloading and the anabolic 
nature of protein ingestion, nutritional interventions have focused primarily on increasing 
protein or essential amino acid (EAA) intake (Dirks et al., 2018; Wall and van Loon, 
2013). Supplementation with high doses of EAA during periods of bed rest has shown 
some success in attenuating muscle mass and strength loss likely via attenuation of 
MPS reductions (Magne et al., 2013; Paddon-Jones et al., 2004; Stein et al., 2003). 
Likewise, treatment with high doses of whole protein supplementation have 
demonstrated limited efficacy in attenuating disuse atrophy (Dirks et al., 2014a; Mitchell 
et al., 2017; Stuart et al., 1990; Stein et al., 2003; Trappe et al., 2007). Trappe et al. 
(2007) found no reversal of muscle mass or strength loss with a high protein diet (1.6 
g/kg body mass/day dietary protein) during 60 days bed rest in otherwise healthy 
women. Similarly, a short-term disuse period, 7-day bed rest, a higher dose of protein 
failed to maintain muscle mass despite improving net nitrogen balance (Stuart et al., 
1990). Recent work by Mitchell et al. (2017) demonstrated that despite an increase in 
myofibrillar protein synthesis following immobilization with protein supplementation, 
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muscle size was not maintained or recovered to a greater extent with concurrent 
physical rehabilitation compared to controls. It has been postulated that those studies 
which have observed beneficial responses to muscle mass and strength with 
protein/EAA supplementation (Baptista et al., 2010; Magne et al., 2012; Paddon-Jones 
et al., 2004) might have actually been due to an the general benefits of providing 
sufficient protein intake and not specifically responding to disuse (Stein and Blanc, 
2011). As such, nutritional supplementation interventions have yielded mixed results, 
and given the cost/volume of EAAs required to maximally stimulate MPS and maintain 
muscle function during disuse, this therapeutic intervention is limited in its efficiency and 
practicality, especially for longer periods of disuse. 
  A more efficacious therapy for the treatment of disuse atrophy has been physical 
rehabilitation. Exercise is the most commonly prescribed therapy to help recover disuse-
mediated losses to muscle mass and strength. Given that it is a strong anabolic stimuli, 
resistance exercise during and after periods of physical inactivity has resulted in 
significant improvements to both muscle size and strength in young, healthy subjects 
(Brooks et al., 2008; Oates et al., 2010; Trappe et al., 2007). Following HLS, adult 
rodents consistently demonstrate significant recovery to muscle mass and force 
production following reload (Baehr et al., 2016; Gallegly et al., 2004; Jackson et al., 
2012; Mitchell and Pavlath, 2004) similar to human subjects undergoing physical 
rehabilitation post-bed rest and immobilization (Tanner et al., 2015; Thompson, 2002). 
Interestingly, the use of neuromuscular electrical stimulation (NMES) has shown some 
promising results in the attenuation of muscle loss with disuse (Dirks et al., 2014b; Miller 
et al., 2018; Reidy et al., 2017). However, despite the efficacy of rehabilitation in young, 
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healthy subjects, in certain situations the degree of immobilization or illness-mediated 
disuse is too great for physical rehabilitation to overcome (Dirks et al., 2018). 
Specifically, the aged population fails to recover muscle loss post-disuse despite 
extended rehabilitative programs (Baehr et al., 2016; Hvid et al., 2010; Suetta et al., 
2009; White et al., 2015). Interestingly, the magnitude of muscle size and function loss 
is essentially the same between young and aged subjects (Siu et al., 2005; Suetta et al., 
2009; White et al., 2015), but the response to pro-anabolic stimuli is blunted in the aged 
population (Hvid et al., 2010; White et al., 2015). This incomplete recovery indicates that 
this muscular reload might be insufficient to fully stimulate regrowth of atrophied muscle 
in the aged population. Importantly, this incomplete recovery is most prominent in aged 
individuals who are most likely to suffer from disuse atrophy, leading to an increased 
risk of developing sarcopenia, disability, and reduced quality of life compared to healthy, 
young counterparts.  
 
2.6 Conclusion 
 Skeletal muscle disuse atrophy results in significant physical complications, 
exacerbating existing comorbidities in both young and aged populations. In addition to 
the specific detriments to skeletal muscle morphology and physiology, related 
disruptions to muscle vascularization along with changes to mononuclear cell function 
within atrophied muscles further complicate the etiology of this condition. Despite some 
promising findings with nutritional and exercise-related therapies, it appears these 
interventions are unable to completely ameliorate muscle atrophy post-disuse, and thus, 
alternative strategies must be explored. 
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PERICYTE TRANSPLANTATION IMPROVES SKELETAL MUSCLE RECOVERY 
FOLLOWING HINDLIMB IMMOBILIZATION 
3.1 Abstract 
 Skeletal muscle disuse atrophy is a significant consequence of physical inactivity 
and limb immobilization resulting in substantial losses to skeletal muscle mass and 
strength. However, rehabilitation can be insufficient to fully stimulate muscle recovery, 
especially in older adults. Pericytes (NG2+CD31-CD45- (Lin-) and CD146+Lin-) are 
perivascular stem/stromal cells that are able to recover injured tissues; however, their 
contribution and efficacy in enhancing muscle growth following immobilization is 
unknown. In this study, 3-4 month-old male C57BL/6 mice were unilaterally immobilized 
for 14 days. Immediately before 14 days of remobilization, the atrophied muscle was 
injected with both NG2+Lin- and CD146+Lin- populations via a low molecular weight 
RGD-alginate hydrogel delivery vehicle followed by histological assessments of skeletal 
muscle regrowth. Changes to perivascular stem/stromal cell quantity and function were 
assessed in non-treated, immobilized mice as well. Perivascular stem/stromal cell 
quantity was significantly reduced with immobilization (p<0.05), but was restored to 
contralateral levels following remobilization. Small alterations to factors associated with 
vascularization and myogenesis were observed in pericytes isolated following 
remobilization. Pericyte co-transplantation resulted in a significant recovery of myofiber 
cross sectional area compared to vehicle alone (p=0.01) concurrent with improvements 
to capillarization. These findings suggest pericyte transplantation into atrophied skeletal 
muscle prior to rehabilitation can improve muscle recovery in adult mice. 
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 Skeletal muscle disuse atrophy is a debilitating medical condition caused by 
physical inactivity, muscular unloading, and/or neuronal inactivation (Brooks and 
Myburgh, 2014). The hazardous health consequences associated with physical 
inactivity are well documented, and include increased susceptibility to comorbidities, 
such as obesity, Type II diabetes, hypertension, atherosclerosis, and cardiovascular 
disease (Atherton et al., 2016; Bergouignan et al., 2011). Mechanical unloading (via 
immobilization or bed rest) is required to allow for proper healing and recovery in 
response to injury or disease, thus atrophy may be unavoidable (English and Paddon-
Jones, 2010; Wall et al., 2013). Even brief periods of inactivity result in significant and 
quantifiable losses to skeletal muscle mass and strength as well as detrimental 
alterations to body composition and metabolic profile (Deutz et al., 2013; Dirks et al., 
2016; Drummond et al., 2012; Kortebein et al., 2007; Mikines et al., 1991; Tanner et al., 
2015). These changes occur rapidly, and can persist even with physical rehabilitation, 
particularly in aged populations, as mobility may be limited, mechanical load insufficient, 
or duration too brief to fully stimulate muscle recovery (Baehr et al., 2016; Hvid et al., 
2010; Hwee and Bodine, 2009; Slimani et al., 2012; Suetta et al., 2013; Wall and van 
Loon, 2012; White et al., 2015; Zarzhevsky et al., 1999). Similarly, nutritional 
supplementation appears to have limited benefits in either attenuating or recovering 
disuse-mediated muscle mass and strength loss (Brooks et al., 2008; English et al., 
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2016; Galvan et al., 2016; Magne et al., 2013; Paddon-Jones et al., 2004). The inability 
to recover lost muscle mass and function post-disuse leads to further disability and an 
overall reduced quality of life (Covinsky et al., 2003). Unfortunately, there are no reliable 
therapies (pharmacological or otherwise) currently available to improve skeletal muscle 
recovery after disuse atrophy. 
 The primary myogenic progenitor cell within skeletal muscle is the satellite cell 
(Pax7+; SC), which resides between the basal lamina and sarcolemma of myofibers 
(Dumont et al., 2015). It is well established that SCs are vital to the regenerative 
process following muscle injury (Lepper et al., 2011; McCarthy et al., 2011; Relaix and 
Zammit, 2012; Sambasivan et al., 2011; Yin et al., 2013), but the SC response to 
atrophy and their subsequent contribution to muscle recovery post-disuse have yielded 
conflicting results. Variable changes to SC content and activation post-immobilization or 
bed rest in both human and rodents have been observed (Arentson-Lantz et al., 2016; 
Brooks and Myburgh, 2014; Mitchell and Pavlath, 2004; Snijders et al. 2014; Suetta et 
al., 2013). However, seminal work by Jackson et al. (2012) directly investigated the 
necessity of SCs to the recovery process following hindlimb suspension. They observed 
that the targeted depletion of SCs using Pax7CreER/+; Rosa26DTA/+ mice prior to 
hindlimb suspension resulted in no difference to muscle weight, myofiber cross 
sectional area (CSA), or single myofiber force production after reload, suggesting SCs 
are not integral to muscle recovery. However, the impact of non-satellite stem cells on 
skeletal muscle atrophy and regrowth following disuse remains unknown. 
 Pericytes are a population of perivascular stem/stromal cells that enwrap the 
endothelial cells of microvessels and capillaries (Armulik et al., 2005; Caplan and 
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Correa, 2011; Díaz-Flores et al., 2009; Sims, 1986), and are vital to microvessel stability 
and regulation of angiogenesis. Residing in physical contact with adjacent endothelial 
cells also allows for direct cell-to-cell communication via paracrine factor secretion, 
promoting vascular stability, and blood flow regulation (Chatterjee and Naik, 2012; 
Gerhardt and Betsholtz 2003). In addition to their role in vascular homeostasis, 
pericytes function as multipotent stem/stromal cells with mesodermal differentiation 
potential (Caplan, 2010). Thus, these cells are able to contribute to tissue repair directly 
through engraftment and new tissue formation or indirectly via growth factor secretion 
(Boppart et al., 2013; Caplan and Correa, 2011). Muscle-derived pericytes have been 
shown to be myogenic in vitro as well as in vivo with pericyte transplantation into injured 
or dystrophic muscle resulting in new myofiber formation (Birbrair et al., 2013; Crisan et 
al., 2008; Dellavalle et al., 2007; Sacchetti et al., 2016). Our laboratory has also 
demonstrated that intramuscular transplantation of perivascular stem cells (Sca-
1+CD45-; CD146+/NG2+) in combination with eccentric exercise contributes to increased 
satellite cell proliferation, myofiber size and strength, and microvessel quantity and 
lumen diameter (Huntsman et al., 2013; Zou et al., 2015). However, the pericyte 
response to disuse and their contribution to muscle recovery remains unknown. 
 The purpose of this study was to determine the pericyte response and direct 
contribution to skeletal muscle recovery following immobilization. We hypothesized that 
pericyte transplantation in immobilization-induced atrophied muscle would enhance 






 3-4 month-old, male C57BL/6 mice obtained from Charles River were used for all 
experiments. Mice were housed in a pathogen-free animal room under controlled 
conditions (12-hour light/dark cycle, 25°C) and maintained on standard chow (Harlan 
Teklad Rodent Diet 7012). Upon arrival, mice were acclimatized to their new 
environment for seven days followed by hindlimb immobilization. The Institutional 
Animal Care and Use Committee of the University of Illinois at Urbana-Champaign 
approved all animal procedures. 
 
Hindlimb immobilization and remobilization procedures 
 Unilateral, lower limb immobilization was performed on mice as described 
previously (Caron et al., 2009; Ebert et al., 2012;). While anesthetized with isoflurane, 
the right foot was securely pinned in full dorsiflexion using a Covidien Royal AutoSuture 
35W skin stapler (eSutures, Mokena, IL, USA) exploiting normal murine dorsotibial 
flexion to induce significant atrophy of the tibialis anterior (TA) muscle. One tine of the 
metal clip was inserted into the plantar portion of the foot with the other tine being 
inserted into the distal portion of the gastrocnemius muscle. The left, contralateral limb 
was untreated and served as an internal control. All mice (n=5-6 per experiment) were 
immobilized for 14 days (IM) then the metal clip was removed under anesthesia using a 
surgery staple remover. A cohort of mice was then remobilized for an additional 14 days 
(RE) prior to euthanasia. Mice were euthanized using carbon dioxide asphyxiation, 
which was confirmed by cervical dislocation. 
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Skeletal muscle mononuclear cell isolation procedure 
 Each TA muscle was dissected and weighed then washed in cold 1x PBS with 
penicillin-streptomycin antibiotic (Thermo Fisher Scientific, Grand Island, NY, USA). The 
cleaned muscle tissue was mechanically minced and enzymatically digested for 
approximately 30 minutes at 37°C. The enzyme solution contained 250 U/mL 
collagenase Type 2 (Worthington-Biochemical Corp., Lakewood, NJ, USA), 2 U/mL 
neutral protease (Dispase) (Worthington-Biochemical Corp.), 60 U/mL DNase (Sigma-
Aldrich, St. Louis, MO, USA), and 2.5 mM CaCl2 in 1x PBS. The tissue solution was 
filtered through a 70 µm then 40 µm filter, resulting in a mononuclear cell suspension. 
Cells were incubated for 10 minutes on ice with anti-mouse CD16/CD32 (Thermo Fisher 
Scientific) to block Fc-mediated nonspecific binding. Post-blocking, cells were incubated 
with a cocktail of antibodies designed for either flow cytometry analysis or fluorescence-
activated cell sorting (FACS) (described below). Following antibody incubation, cells 
were centrifuged for 5 minutes at 300 RCF and supernatant discarded. Cell pellet was 
resuspended in 2% FBS in 1x PBS and filtered through a 40 µm filter then placed on 
ice. 
 
Flow cytometry and fluorescence-activated cell sorting (FACS) 
 Skeletal muscle perivascular stem/stromal cell population quantity was analyzed 
using multiplex flow cytometry. Isolated mononuclear cells were incubated for 45 
minutes at 4°C with conjugated anti-mouse NG2 (chondroitin sulfate proteoglycan-4)-
Alexa Fluor 488 (1:50; Millipore-Sigma, Burlington, MA, USA; AB5320A4), CD146 
(melanoma cell adhesion molecule)-phyocerythrin (PE) (Clone ME-9F1) (1:50; 
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BioLegend, San Diego, CA, USA; #134704), CD140A (Platelet derived growth factor 
receptor alpha)-BV421 (Clone APA5) (1:50; BD Biosciences, San Jose, CA, USA; 
#566293), CD31 (PECAM-1)-allophycoctanin (APC) (Clone MEC 13.3) (1:100; BD 
Biosciences; #561814), and CD45-APC (Clone 30-F11) (1:100; BD Biosciences; 
#561018) antibodies diluted in 2% FBS in 1x PBS. Stained cells were analyzed using a 
four laser BD LSRFortessa™ Cell Analyzer (403-nm violet, 488-nm blue, 561-nm 
yellow/green, 640-nm red lasers) (BD Biosciences) at the Flow Cytometry Center at the 
University of Illinois at Urbana-Champaign (UIUC) Roy J. Carver Biotechnology Center 
(CBC) (Urbana, IL, USA). Unstained and single stained control samples were analyzed 
in order to account for potential spectral overlap between fluorophores and compensate 
accordingly. Fluorescence minus one (FMO) controls were utilized to establish proper 
gating parameters. Approximately 50,000 events were recorded for each sample and 
FMO. All flow cytometry data was analyzed using FCS Express Flow Cytometry 
Software (Ver. 5) (De Novo Software, Glendale, CA, USA). 
 NG2+Lin- (CD31-CD45-) and CD146+Lin- skeletal muscle pericytes were sorted 
using a BD FACS Aria II sorter by the Flow Cytometry Center at the UIUC CBC 
(Urbana, IL, USA). NG2+Lin- pericytes were stained with conjugated anti-mouse NG2-
Alexa Fluor 488 (1:50), CD31 (PECAM-1)-APC (Clone MEC 13.3) (1:100), and CD45-
APC (Clone 30-F11) (1:100) antibodies. CD146+Lin- pericytes were stained with 
conjugated anti-mouse CD146-PE (Clone ME-9F1) (1:50), CD31-fluorescein 
isothiocyanate (FITC) (Clone 390) (1:100, Thermo Fisher Scientific; #11-0311-81), and 
CD45-FITC (Clone 30-F11) (1:100; Thermo Fisher Scientific; #11-0451-81) antibodies. 
All antibodies were diluted in 2% FBS in 1x PBS. Appropriate unstained and single 
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stained samples were run to establish proper gating. For gene expression analysis, 
NG2+Lin- and CD146+Lin- pericyte populations were sorted separately as previously 
described (Khan et al., 2016). Briefly, approximately 20,000 cells were sorted directly 
into 500 µL of Buffer RLT (Qiagen, Valencia, CA, USA) with 5 µL β-mercaptoethanol 
being added immediately after collection followed by RNA extraction. For 
transplantation experiments, pericyte populations were collected separately in pericyte-
specific growth media (high glucose Dulbecco’s Modified Eagle’s Medium (DMEM), 
10% FBS, 1% penicillin-streptomycin) and seeded on tissue culture dishes incubated at 
37°C and 5% CO2 to allow for recovery and short-term expansion up to 80-90% 
confluency.  
 
Gene expression analysis using real-time quantitative polymerase chain reaction 
(qPCR) 
 RNA was extracted from cell lysates using RNeasy Micro Kit (Qiagen), following 
the manufacturer’s instruction. Quantity of isolated RNA was assessed in duplicate on a 
Take-3 application plate using a Synergy H1 Hybrid Multi-Mode Microplate Reader 
(BioTek, Winooski, VT, USA). Starting RNA concentration of 25 ng was used to perform 
reverse transcription via the High Capacity cDNA Reverse Transcription Kit (Life 
Technologies, Grand Island, NY, USA) per manufacturer’s instructions. Preamplification 
of cDNA was completed using TaqMan PreAmp Master Mix Kit (Life Technologies). 
qPCR was performed using the 7900HT Fast Real-Time PCR System with TaqMan 
Universal PCR Master Mix (Applied Biosystems, Grand Island, NY, USA) by the 
Functional Genomics Unit in the UIUC CBC (Urbana, IL). All genes were normalized to 
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the geometric mean of beta-actin (Actb), glyceraldehyde-3-phosphate dehydrogenase 
(Gapdh), and hypoxanthine-guanine phosphoribosyltransferase (Hprt) and expressed 
relative to the respective contralateral limb control. Gene expression data was 
calculated using the ΔCt method. Inventoried TaqMan primers were purchased from 
Applied Biosystems/Thermo Fisher Scientific. Primer information and gene expression 
assay ID numbers are provided in Supplementary Table 3.1. 
 
DNA plasmid extraction and pericyte transfections 
 For pericyte transplantation experiments, separately cultured NG2+Lin- and 
CD146+Lin- pericytes were transfected with either ZsGreen1-N1 or tdTomato-N1 
plasmids purchased from Addgene (Cambridge, MA, USA). ZsGreen1-N1 was a gift 
provided by Michael Davidson (Addgene plasmid #54702) and tdTomato-N1 was a gift 
provided by Michael Davidson and Roger Tsien (Addgene plasmid #54642). Plasmids 
were obtained as bacteria in agar stab, which was streaked on Luria broth (LB) agar 
plates with Kanamycin antibiotics (50 µg/mL). Streaked LB agar plates were incubated 
overnight at 37°C. Single colonies were then selected and inoculated in liquid LB with 
Kanamycin (50 µg/mL) overnight at 37°C on a shaker (~200 rpm). Plasmid was 
extracted using the PureYield™ Plasmid Miniprep System (Promega, Madison, WI, 
USA; A1223) following manufacturer’s instructions. Quantity of isolated DNA was 
assessed in duplicate on a Take-3 application plate using a Synergy H1 Hybrid Multi-
Mode Microplate Reader (BioTek). 
 After 9 days of culturing, FACS-isolated pericytes were detached using 
StemPro™ Accutase™ Cell Dissociation Reagent (Thermo Fisher Scientific) and re-
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plated onto separate 35mm2 culture dishes (~500,000 cells/population) and incubated at 
37°C/5% CO2. After 24 hours, pericytes were transfected with isolated plasmids (1 µg) 
(NG2+Lin-: ZsGreen1-N1; CD146+Lin-: tdTomato-N1) using Effectene® Transfection 
Reagent (Qiagen) following manufacturer’s instructions. Twenty-four hours post, 
pericytes were dissociated using Accutase™ and prepared for transplantation.  Pericyte 
transfection was visualized and imaged with an inverted fluorescence and brightfield 
microscope using a Zeiss Axiocam digital camera and Axiovision software (Zeiss, 
Thornwood, NY, USA). 
 
Conjugation of RGD-oligopeptides to alginate 
 As previously described (Lee et al., 2015), 1% weight alginate 
(MW: ∼ 50,000 grams/mole) was dissolved in (N-morpholino)ethanesulfonic acid (MES) 
buffer at pH 6.5 (Sigma-Aldrich). Then, sulfonated N-hydroxysuccimide (Sulfo-NHS) 
(Thermo Fisher Scientific), 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC) 
(Thermo Fisher Scientific) and the oligopeptide sequence, GGGGRGDSP, termed RGD 
peptide (Mimotopes, Richmond, VA, USA) was sequentially added to the alginate 
solution, and then stirred for 24 hours. The molar ratio of uronic acid from alginate, 
sulfo-NHS, EDC and RGD peptide was 1:0.025:0.05:0.0016, corresponding to 2 RGD 
peptides for every 5 alginate chains. The resulting RGD-alginate solution was dialyzed 
against distilled water for 40 hours, while replacing water three times a day. The RGD-
alginate solution was then sterilized via 0.22 µm filtration, lyophilized, and stored at -
20 °C until use.  
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Pericyte transplantation using low molecular weight RGD-alginate hydrogel 
 To prepare the hydrogel, RGD-alginate was reconstituted in phosphate-buffered 
saline (1x PBS) to obtain a 4% w/v solution prior to gelation. After transfection, both 
pericyte populations were collected together and resuspended in the hydrogel solution, 
which was cross-linked with aqueous slurries of calcium sulfate solution (0.21 g 
CaSO4 /mL distilled water) at a molar ratio of 1:0.25 (40 µL of CaSO4 per 1 mL of 4% 
w/v alginate solution). The solutions were mixed with two, 1 mL syringes connected via 
a syringe connector, and by pushing the solutions from one syringe to the other 20 
times (Kong et al., 2003). On Day 14 of immobilization, immediately prior to 
remobilization, immobilized hindlimbs were unclipped and the immobilized TA was 
intramuscularly injected in the midbelly with either pericyte-loaded hydrogel (~50,000 
cells in 30 µL hydrogel; comprised of ~25,000 cells per population) or RGD-alginate 
hydrogel solution alone. The contralateral TA was untreated. Mice were remobilized for 
a 14 days then TA muscles collected and preserved for immunofluorescence analysis. 
 
Skeletal muscle immunofluorescence 
  Excised TA muscles were weighed and rapidly frozen in liquid nitrogen-
cooled isopentane and stored at -80°C. For tissue sectioning, muscles were separated 
at the midbelly along the axial plane and embedded in OCT (Tissue-Tek; Fisher 
Scientific, IL, USA). Transverse sections (10 µm non-serial sections, separated by at 
least 50-80 microns) were then cut using a CM3050S cryostat (Lecia, Wezlar, 
Germany), placed on microscope slides (Superfrost; Fisher Scientific), and stored at -
80°C until staining. 
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 Muscle sections were fixed in ice-cold acetone for 15 minutes and then washed 
with 1x PBS. Sections were blocked for 1 hour at room temperature with AffiniPure Fab 
Fragment goat anti-mouse IgG (H+L) (55 µg/mL; Jackson ImmunoResearch 
Laboratories, Inc., West Grove, PA, USA; #115-007-003) in 5% bovine serum albumin 
(BSA) with 0.05% Tween-20 in 1x PBS. To assess myofiber cross sectional area (CSA), 
myonuclei content, and muscle capillarization, sections were incubated with rat anti-
mouse CD31 (Clone 390) (1:100; Thermo Fisher Scientific; #14-0311-82) and rabbit 
anti-mouse dystrophin (1:100; Abcam, Cambridge, MA, USA; ab15277). To assess 
collagen accumulation and macrophage infiltration, sections were incubated with rat 
anti-mouse CD11b (1:200; eBioscience; #14-0112-81) and rabbit anti-mouse Collagen 
Type I (1:100; Abcam; ab34710). To assess ZsGreen plasmid (NG2+Lin- pericyte) and 
tdTomato plasmid (CD146+Lin- pericyte) localization post-transplantation, sections were 
incubated with rat anti-mouse Laminin α-2 (Clone 4H8-2) (1:100; Santa Cruz 
Biotechnology, Dallas, TX, USA; sc-59854) and either rabbit anti-mouse ZsGreen (1:75; 
Takara Bio USA, Inc.; #632474) or rabbit anti-mouse DsRed (1:100; Takara Bio USA, 
Inc., Mountain View, CA, USA; #632496). All primary antibodies were applied for 1 hour 
at room temperature in Wash Buffer (1% BSA with 0.05% Tween-20 in 1x PBS). Goat 
anti-rat Alexa Fluor 488 (1:100; Thermo Fisher Scientific; #A-11006), goat anti-rabbit 
Alexa Fluor 633 (1:200; Thermo Fisher Scientific; #A-21070), goat anti-rat Alexa Fluor 
633 (1:100; Thermo Fisher Scientific; #A-21094), or goat anti-rabbit FITC (1:150; 
Jackson ImmunoResearch; #11-095-144) secondary antibodies were diluted in Wash 
Buffer and applied as appropriate for 1 hour at room temperature. Finally, sections were 
stained with 4’,6-diamidino-2-phenylindole (DAPI) (1:20,000; Sigma-Aldrich, St. Louis, 
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MO, USA) to identify nuclei. After each staining procedure, slides were mounted with 
Vectashield mounting media (Vector Laboratories, Burlingame, CA, USA) and stored at 
4°C. Tissue sections were visualized using an inverted fluorescent microscope and 
images were acquired at 20x magnification with a Zeiss Axiocam digital camera and 
Axiovision software (Zeiss, Thornwood, NY, USA). Images were acquired in separate 
color channels to allow for independent analysis of images (CD31/CD11b/ZsGreen – 
FITC channel; dystrophin/collagen Type I/DsRed – TRITC channel). 
 
Immunofluorescence image analysis 
 To quantify myofiber CSA, dystrophin-Alexa Flour 633 images were imported into 
Adobe Photoshop (CS5 Extended) and an average of 400 fibers were circled using the 
magnetic lasso tool, which decreases subjectivity and interassessment error (Zou et al., 
2015). To assess myonuclei content, the number of total myonuclei contained per 
myofiber (~200 fibers/sample) was recorded using ImageJ (NIH). Muscle capillarization 
was determined using five, random 20x images per sample as described previously 
(Huntsman et al., 2013). Measures of capillary-to-fiber ratio (number of capillaries per 
total number of myofibers) and capillary density (number of capillaries per muscle fiber 
area) were determined for each image by quantifying (per image) the total number of 
transversely cut capillaries, the number of myofibers, and the total area (mm2) of the 
imaged muscle section.  
 TA collagen content was quantified with a threshold intensity program from 
ImageJ. RGB channels were separated and then the red channel was thresholded to 
remove background in order to determine the percent of collagen observed within each 
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imaged muscle section. Six, random 20x images were analyzed per sample normalized 
to muscle area. Skeletal muscle macrophage infiltration was analyzed by quantifying the 
number of CD11b+DAPI+ cells per field of view (FOV). Approximately 10 images per 
sample were obtained at 20x magnification and number of CD11b positive cells co-
localizing with DAPI was recorded. Any punctate CD11b staining not overlapping with 
DAPI was excluded. 
 
Statistical analysis 
 All data is presented as mean ± standard error of the mean (SEM). Paired 
sample t-tests were conducted for all within subject analyses (Stapled/treated versus 
Mobile/contralateral limbs). Independent sample t-tests were used for to compare the 
magnitude of the paired, immobilization differences between groups (Stapled–Mobile for 
IM versus RE or Control-Hydrogel versus Pericyte-Hydrogel). All statistical analyses 
were completed using SPSS Ver. 24 (IBM, Chicago, IL, USA). Differences were 











Unilateral hindlimb immobilization results in reductions to perivascular stem/stromal cell 
quantity that is restored with remobilization. 
 Following 14 days of unilateral immobilization (“IM”), both absolute (mg) and 
relative (mg/g body weight) tibialis anterior (TA) muscle weight was significantly reduced 
in the immobilized limb (“Stapled”) compared to the contralateral control limb (“Mobile”) 
(p=0.001) (Figure 1A and B). As previously observed (Caron et al., 2009), following 14 
days of hindlimb remobilization (“RE”), the Stapled muscle weights remained 
significantly reduced compared to Mobile (p=0.001) (Figure 1A and B). The magnitude 
of the paired difference in relative muscle weights between Stapled and Mobile limbs for 
both IM and RE was not significantly different (Figure 1C). In order to confirm previous 
findings regarding concurrent reductions to myofiber cross sectional area (CSA) with 
muscle weight loss, we quantified CSA at both IM and RE using dystrophin 
immunofluorescence on separate cohorts of mice. We observed significant reductions 
to TA myofiber CSA between hindlimbs (Mobile vs. Stapled) following IM and RE (IM: 
1835 ± 134 vs. 1335 ± 143 µm2, p=0.02, n=4; RE: 1833 ± 194 vs. 1371 ± 63 µm2, 
p=0.05, n=4) that were concurrent with the TA muscle weight loss.  
 Figure 1D presents the gating parameters for quantification of perivascular 
stem/stromal cell content using multiplex flow cytometry. After excluding any doublets 
from gated mononuclear cells, all CD31 (endothelial)/CD45 (immune) expressing cells 
were likewise excluded (CD31-CD45-; Lineage-). From the Lineage- (Lin-) population, 
selection for NG2+, CD146+, and PDGFRα+ cells resulted in the specific quantification of 
pericyte (NG2+Lin- and CD146+Lin-) and fibro/adipogenic progenitor (PDGFRα+Lin-; 
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FAP) populations from Mobile and Stapled limbs. Assessing baseline perivascular 
stem/stromal cell quantity from separate, control mice (n=3) revealed that NG2+Lin- 
pericytes were 12.6 ± 1.2%, CD146+Lin- pericytes were 54.8 ± 1.9%, and PDGFRα+Lin- 
FAPs were 10.6 ± 1.4% of all gated mononuclear cells. After 14 days of immobilization, 
no difference in the percentage of Lineage+ (CD31+/CD45+) expressing cells was 
observed between Stapled and Mobile limbs (Figure 1E). A significant reduction in the 
percentage of NG2+Lin- pericytes was detected with immobilization (p=0.01) while there 
was a trend for a decrease in the number of CD146+Lin- pericyte and PDGFRα+Lin- FAP 
populations (CD146+Lin-, p=0.06; PDGFRα+Lin-, p=0.07). However, post-remobilization, 
no significant differences were observed between Mobile and Stapled muscles in any of 
the perivascular stem/stromal cell populations.  
 Lineage+ expression within the different perivascular stem/stromal cell 
populations between limbs was unaffected by immobilization (Figure 1F). The 
percentage of NG2+ and CD146+ cells expressing Lin was approximately 70% while 
only 20% of PDGFRα+ cells expressed Lineage markers following IM. After 14 days of 
remobilization the percentage of NG2+ and CD146+ cells expressing Lin was reduced to 
~50% and 60% respectively while PDGFRα+ cells remaining unchanged (Figure 1F). 
 No difference was detected in the percentage of NG2+Lin- pericytes expressing 
CD146+ after 14 days of immobilization but a trend for a reduction was detected after 
remobilization (p=0.08) (Figure 1G). Following immobilization, the percentage of 
CD146+Lin- pericytes expressing NG2 trended for a decrease (p=0.06) but was 
recovered with remobilization (Figure 1H). The large overlap of CD146 expression 
within the NG2+Lin- pericyte population concurrent with the minimal overlap of NG2 
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expression with the CD146+Lin- pericyte population suggests that NG2+Lin- pericytes 
might represent a subpopulation of the greater CD146+Lin- pericytes population 
 
Pericyte gene expression profiles are similar between atrophied and contralateral 
control limbs following remobilization despite no recovery to skeletal muscle weight. 
 Two cohorts of mice were used to assess the gene expression profiles for both 
NG2+Lin- and CD146+Lin- pericytes to determine the impact of hindlimb immobilization 
with remobilization on pericyte function. We chose to assess functional changes 14 
days after remobilization due to the lack of muscle weight recovery we previously 
observed, thus we speculated that differences in gene expression signatures would 
persist in immobilized versus control limbs even at this extended time point. In 
agreement with our findings in Figure 1, significant reductions to TA muscle weight were 
observed in Stapled limbs after remobilization for both cohorts (p<0.05) (Figure 2A and 
B). The magnitude of the muscle weight decrease was not different between cohorts 
(Figure 2C). For both pericyte populations, genes associated with growth factors (GF), 
vascularization (VAS), myogenesis (MYO), extracellular matrix proteins (ECM), and 
neurotrophic factors (NEURO) were examined. Comparing the relative mRNA 
expression of Stapled to Mobile limbs revealed few differences in expression for either 
population. NG2+Lin- pericytes demonstrated significant reductions in the relative 
expression of vascular endothelial growth factor (Vegfa) (p=0.04) and the myogenic 
transcription factor, Pax7 (p=0.05), as well as non-significant reductions in expression of 
angiogenin (Ang) (p=0.09) and collagen type 1, α1 (Col1a1) (p=0.06) (Figure 2D). A 
trend for increased growth differentiation factor-11 (Gdf11) expression was also noted 
	59	
(p=0.08). Similarly, CD146+Lin- pericytes exhibited minimal differences in relative mRNA 
expression between limbs (Figure 2E). A significant reduction in leukemia inhibitory 
factor (Lif) expression was detected (p=0.05) with non-significant increases in 
expression observed for myogenin (Myog) (p=0.06), matrix metalloproteinase 9 (Mmp9) 
(p=0.07), and the irisin precursor, Fndc5 (p=0.06).  
 
Pericyte co-transplantation into atrophied skeletal muscle results in increased myofiber 
cross sectional area. 
 The pericyte transplantation experimental design is presented in Figure 3A.  
Following hindlimb immobilization, a separate group of C57BL/6 mice were used for the 
collection of NG2+Lin- and CD146+Lin- pericytes, which were then cultured individually 
for 9 days. On Day 13, NG2+Lin- pericytes were transiently transfected with a 
ZsGreen1-N1 plasmid and CD146+Lin- pericytes were transiently transfected with a 
tdTomato-N1 plasmid. Figure 3B presents representative images of the pericytes 24 
hours after transfection. On Day 14, pericytes were resuspended in a low molecular 
weight RGD-alginate hydrogel solution for intramuscular transplantation into atrophied 
TA muscles followed by 14 days of remobilization. 
 Both the control (“Hydrogel”) and treated (“Pericyte”) mice exhibited no significant 
differences in absolute or relative muscle weight after remobilization (Figure 4A and B) 
with the paired limb differences being similar regardless of treatment (Figure 4C).  
However, global myofiber CSA was significantly reduced in the Stapled limb of the 
Hydrogel group (p=0.002) while no difference in CSA was detected between limbs in the 
Pericyte-treated group (Figure 4D). The paired limb difference was significantly different 
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between the control and treated groups (Hydrogel, -230.43 ± 39.23 vs. Pericyte, -14.52 
± 53.79; p=0.01) (Figure 4E). Representative images of Mobile and Stapled muscle 
sections stained with Dystrophin (red) and DAPI (blue) in both Hydrogel and Pericyte 
groups are presented in Figure 4F. 
 Myofiber size distribution analysis detected a significant increase in the 
percentage of fibers in the size range of 1000-1500 µm2 in the Stapled limb of the 
Hydrogel control group (p=0.01) with a trend for an increase in the range of 500-1000 
µm2 (p=0.07). Additionally, there was a significant decrease in the percentage of large 
myofibers >3500 µm2 in the Stapled limb of the Hydrogel control group (p=0.004). A 
trend for an increase in the percentage of fibers ranging from 2000-2500 µm2 in the 
Stapled limb of the Pericyte group was also observed (p=0.08) (Figure 4G). Comparing 
the paired limb difference between the Hydrogel and Pericyte groups, the Hydrogel 
group had a relative increase in the percentage of fibers with smaller CSA (500-1000 
and 1000-1500 µm2) (p=0.02 and p=0.01, respectively) while the Pericyte group had a 
higher, albeit non-significant (p=0.17), percentage of medium sized fibers at the 2000-
2500 µm2 range (Figure 4H).   
 
No increase in collagen accumulation or macrophage infiltration is observed following 
low molecular weight RGD-alginate hydrogel pericyte transplantation. 
 The percentage of Collagen Type I present in immobilized TA muscles was not 
significantly different from contralateral limbs (Figure 5A and B). Figure 5C provides a 
representative image of Collagen Type I (red) and DAPI (blue) co-staining. Total 
CD11b+ macrophage content was very low and not affected by either immobilization or 
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treatment (Figure 5D and E). A representative image of a CD11b+DAPI+ macrophage 
within a TA muscle section is presented in Figure 5F. 
 
No myonuclear accretion or myofiber regeneration is observed following remobilization 
or pericyte transplantation. 
 The percentage of myofibers containing centrally located nuclei was not 
significantly increased following remobilization of either Hydrogel or Pericyte groups 
(Figure 5G and H). Likewise, the myonuclei-to-fiber ratio, which can be used as an 
indicator of myonuclear accretion (Jackson et al., 2012; McCarthy et al., 2011), was not 
different between limbs or with treatment (Figure 5I and J). 
 
Pericyte transplantation significantly enhances skeletal muscle capillarization following 
hindlimb immobilization. 
  Figure 6A is a representative image of the CD31/dystrophin 
immunofluorescence staining used to quantify TA capillarization. Following 
immobilization, the Stapled TA had a significantly reduced capillary-to-fiber ratio 
(p=0.01), which was recovered with pericyte transplantation (Figure 6B). The paired 
limb difference was significantly decreased in the Hydrogel group while it remained 
unchanged in the pericyte-treated group (Hydrogel, -0.26 ± 0.05 vs. Pericyte, 0.06 ± 
0.06 #/fiber; p=0.003) (Figure 6C). Capillary density was not reduced in the Stapled limb 
of the Hydrogel group, while it was significantly increased with pericyte co-
transplantation (p=0.02) (Figure 6F). A significant increase in the capillary density 
between limbs was observed in the Pericyte group compared to controls (Hydrogel, -
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19.61 ± 23.96 vs. Pericyte, 99.24 ± 26.17 #/mm2; p=0.01) (Figure 6G). A strong, 
negative relationship was observed correlating both the C/F ratio (Figure 6D) and 
capillary density (Figure 6F) to myofiber CSA between hindlimbs in the Pericyte treated 
group (C/F ratio: r=-0.82, p=0.09; capillary density: r=-0.80, p=0.10). In the Hydrogel 
control group, weak capillarization and myofiber CSA correlations were observed 
between hindlimbs (C/F ratio: r=0.29, p=0.58; capillary density: r=-0.35, p=0.50) (Figure 
6D and G). 
 
Transplanted pericytes localize to distinct areas around skeletal muscle myofibers in a 
population-specific fashion. 
 In an attempt to determine pericyte localization following transplantation the 
different pericyte populations had been transfected with reporter plasmids prior to 
injection. However, we failed to visually detect the reporter 14 days after transfection. 
Thus, we performed immunofluorescence analysis of the reporter plasmids for a 
qualitative assessment of pericyte localization (Figure 7). We did not observe plasmid 
content within the myofibers, but rather we detected pericyte localization in between and 
around the myofibers. Specifically, NG2+ pericytes appeared to reside within the 
basement membrane, as identified by overlap of laminin α2 with the ZsGreen plasmid 
(Figure 7A), while CD146+ pericytes appear to localize in the interstitum between 






 The purpose of this study was to assess the pericyte response to disuse and the 
efficacy of a pericyte transplantation therapy on skeletal muscle recovery following 
hindlimb immobilization. Despite both pericyte populations demonstrating limited 
functional differences with remobilization following hindlimb immobilization, a full 
restoration of perivascular stem/stromal cell quantity was observed in atrophied TA 
muscles post-remobilization. Utilizing a unique low molecular weight RGD-alginate 
hydrogel delivery system, intramuscular transplantation of NG2+Lin- and Cd146+Lin- 
pericytes resulted in a restoration of TA myofiber size concurrent with increased 
muscular capillarization following a period of disuse. Overall, these findings suggest that 
skeletal muscle-derived pericytes are a viable therapeutic option for improving skeletal 
muscle recovery after limb immobilization.     
 While vitally important in the repair process following injury, satellite cell (SC) 
necessity and direct contribution to myofiber size during mechanical overload or disuse 
is less certain (Brooks et al., 2018; Egner et al., 2016; Jackson et al., 2012; McCarthy et 
al., 2011). In addition to SCs, multiple other mononuclear cell populations within muscle 
can contribute to skeletal muscle homeostasis, including fibro/adipogenic progenitors 
(FAPs), mesenchymal stem cells, and pericytes (Boppart et al., 2013; Tedesco et al., 
2017; Otto et al., 2009). There is growing evidence to suggest that pericytes in 
particular are important for tissue maintenance throughout the body given their ability to 
directly and indirectly assist in tissue repair via physical engraftment or paracrine factor 
release (Armulik et al., 2011; Augello et al., 2010; Murray et al., 2014). Chondroitin 
sulfate proteoglycan 4 (Cspg4/NG2)-positive and melanoma cell adhesion molecule 
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(Mcam/CD146)-positive cells have been identified as two distinct pericyte populations 
residing within skeletal muscle, which can contribute to myofiber growth and recovery 
following injury (Birbrair et al., 2013; Crisan et al., 2008; Sacchetti et al., 2016). Their 
response to muscular disuse and subsequent remobilization, however, has yet to be 
investigated. We show that concurrent with immobilization-induced muscle atrophy, 
pericyte content is substantially decreased. Surprisingly, despite a lack of muscle weight 
recovery following remobilization, pericyte quantity is fully restored suggesting pericytes 
possess a capacity for self-renewal in response to muscular activation and contraction 
irrespective of muscle growth.  
  Pericytes are variably distributed along microvessels and demonstrate specific 
marker and functional differences (Armulik et al., 2011; Díaz-Flores et al., 2009). 
Research has indicated that NG2+ pericytes are located primarily along post-capillary 
venules while CD146+ pericytes are primarily associated with capillaries (Attwell et al., 
2015; Murfee et al., 2005; Vanlandewijck et al., 2018). Despite being distributed along 
the microvasculature differentially, there is still marker expression overlap as well as co-
localization. We note that between 3-4 months of age, ~80% of NG2+Lin- pericytes 
express CD146, while <20% of CD146+Lin- pericytes express NG2. This suggests that 
NG2+ pericytes could represent a smaller, subpopulation that arises from the CD146+ 
pericyte population. This connection might explain the similarity in function and 
differentiation capacity between the two separate populations that have been previously 
reported (Birbrair et al., 2013; Sacchetti et al., 2016). We also observed high overlap of 
Lineage expression within the pericyte populations, but not within the FAP cells. We 
postulate that this supports the general microvessel localization of these different 
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pericyte population as previously described (Attwell et al., 2016), further justifying the 
need for Lineage exclusion in order to isolate a pure pericyte population independent of 
endothelial or immune cell contamination. Research has indicated a specific capacity for 
endothelial cells to behave in a perivascular stem cell manner as well as modulate 
perivascular stem/stromal cell function (Quarta et al., 2017), which if included following 
isolation, can confound the actual mechanism with which pericytes function. Ensuring 
consistent Lineage exclusion is vital to the accurate analysis of pericyte quantity and 
functionality. 
 With the full restoration of pericyte quantity in atrophied muscle after 
remobilization, we investigated whether any functional changes might be observable 
after two weeks of remobilization. NG2+Lin- pericytes had significantly reduced Vegfa 
and Pax7 expression post-remobilization indicating a slightly reduced capacity for NG2+ 
pericytes to mediate angiogenesis and cell quiescence (Ribatti et al., 2011; Zammit et 
al., 2004). Decreases in Ang and Col1a1 as well as a slight increase in Gdf11 
expression also indicates a possible alteration to their ECM remodeling potential post-
disuse, in agreement with previous research demonstrating maladaptive ECM content 
after periods of physical inactivity (Giannelli et al., 2005; Hammers et al., 2017; Li and 
Hu, 2012). CD146+Lin- pericytes had a significant decrease in Lif expression with a 
trending increase in Myog, Mmp9, and Fndc5 expression, possibly corresponding to an 
increase in myogenic capacity of these pericytes (Colaianni et al., 2017; Li et al., 2009; 
Nicola and Babon, 2015; Yin et al., 2013). However, these analyses were completed 14 
days after remobilization, which may have been too far removed from when any 
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noticeable changes might have occurred. Future work will need to investigate the 
specific time course with which these pericytes respond to remobilization. 
   Stem cell transplantation therapy has been extensively studied over the past 50 
years due to their therapeutic potential (Caplan and Correa, 2011; García-Castro et al., 
2008). However, the viability and survival of these cells post-transplantation is poor. 
Thus, other transplantation vehicles are being pursued than the traditional saline or PBS 
vehicle injections in order to improve the efficacy of stem cell therapies. To that end, the 
use of bioengineered hydrogels has been implemented due to their stability, ability to 
improve exogenous cell viability post-transplantation, and biodegradability (Kong et al., 
2003). Low molecular weight RGD-alginate hydrogel transplantation, with and without 
pericytes, resulted in maintenance of TA muscle wet weight, possibly attributable to the 
weight of the transplanted hydrogel. However, we demonstrate for the first time that 
transplantation of both NG2+Lin- and CD146+Lin+ pericytes into atrophied muscle results 
in recovered myofiber size following remobilization. In addition, the percentage of 
smaller fibers that typically increase with immobilization was prevented with pericyte 
transplantation. The presence of exogenous pericytes appears to assist in the 
maintaining of normal myofiber size distribution that is consistently reduced with 
immobilization (Fox et al., 2014). The immobilization model employed in this study 
induces severe atrophy that is not readily ameliorated upon remobilization. Significant 
muscle weight recovery has been shown to be delayed and not occur until 
approximately 4 weeks post-unstapling (Caron et al., 2009). As such, this model is ideal 
in assessing how efficiently pericyte transplantation can be in improving muscle 
recovery. Our findings suggest that pericyte transplantation could be an effective 
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therapeutic tool to improve muscle regrowth in those populations less responsive to 
physical rehabilitation. 
 Importantly, pericyte transplantation did not result in an inflammatory response or 
collagen accumulation, which are common observation in traditional stem cell 
transplantation therapies (Costamagna et al., 2015). A lack of myofiber regeneration or 
myonuclei accretion indicates that neither this immobilization model nor pericyte 
transplantation requires nor initiates a regenerative response two weeks after 
remobilization. The lack of an increase in centrally located nuclei (CLN) upon 
remobilization is in contrast to previous work showing a small, but significant increase in 
the percentage of CLN containing myofibers following a return to ambulation (Jackson 
et al., 2012). The HLS model employed in those studies is consistently seen to stimulate 
full muscle regrowth upon reload (Bodine, 2013), possibly due to the sudden increased 
load placed on the atrophied muscle. This sudden hypertrophic stimulus could result in 
occasional myofiber damage requiring a small amount of regeneration to occur. 
However, in our model, a smaller overall load is placed upon the muscle due to 
increased ankle flexion persisting during remobilization resulting in a reduced range of 
motion (Caron et al., 2009). Therefore, direct muscle activation is likely not occurring to 
the same extent as in HLS with reload, and muscle damage and subsequent 
regeneration upon remobilization is not observed. 
 Capillarization is vital for proper metabolic transfer and gaseous exchange 
between the systemic circulation and muscle tissue (Latroche et al., 2015). In this study, 
we demonstrate significant improvements to muscle capillarization after pericyte 
transplantation into atrophied skeletal muscle. A preservation of the capillary-to-fiber 
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(C/F) ratio indicates that exogenous pericytes can contribute to specific myofiber 
capillarization. Also, a significant increase in the overall capillary density with pericyte 
transplantation suggests exogenous pericytes can mediate capillarization. As pericytes 
are integral in the stabilization of microvessels (Díaz-Flores et al., 2009), it is possible 
the transplanted pericytes are adhering to existing and newly formed vessels, thus 
stabilizing them around the recovering skeletal myofibers.  
 The intricate relationship between blood supply and myofiber functioning is an 
important factor in muscle homeostasis. Previous data regarding the effect of disuse on 
muscle capillary content has been somewhat conflicting due to model differences (Tyml 
and Mathieu-Costello, 2001), but most research suggests that disuse leads to reduced 
muscle vascularization which likely contributes, in part, to muscle size reductions. 
Based upon these findings, it is possible that the recovery of myofiber CSA is related to 
pericyte-mediated improvements to muscle capillarization. Our histological analysis of 
pericyte localization suggests these two populations do not directly engraft with existing 
myofibers or result in de novo myogenesis but migrate to specific locations adjacent to 
myofibers. Interestingly, it appears that the CD146+ pericytes reside in the interstitial 
space between fibers in contrast to the NG2+ pericytes, which seem to localize more 
intimately with myofibers by residing closely or within the basement membrane of 
individual myofibers. This difference in localization suggests a possible deviation in 
functional capacity following transplantation. However, one limitation is that we were 
unable to discern pericyte viability in this study. Low transfection efficiency and previous 
research indicating that the CMV promoter incorporated into our ZsGreen and tdTomato 
reporter plasmids is methylated and silenced over time (Qin et al., 2010) results in 
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decreased fluorescence expression, and thus our ability to detect expression of the 
reporter. Future studies will need to incorporate pericytes isolated from EGFP mice or 
use a stronger plasmid promoter, such as ubiquitin C (UbC), to detect transplanted 
pericytes after 14 days of remobilization. 
 
3.6 Conclusion 
 The findings from this study provide the first evidence that pericytes contribute to 
skeletal muscle recovery following immobilization. This study provides justification for 
further development of a pericyte therapy, as well as parallel studies that identify the 
mechanistic basis by which pericytes increase capillarization and myofiber size 
following disuse atrophy.  
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Figure 3.1. Perivascular stem/stromal cell quantity is reduced following 
immobilization but restored upon remobilization. (A) Absolute and (B) relative 
tibialis anterior (TA) muscle weights are significantly reduced in immobilized (Stapled) 
compared to contralateral control (Mobile) limbs after 14 days immobilization (IM) and 
14 days remobilization (RE). (C) The paired difference between limbs (Stapled–Mobile) 
is not significantly different between IM and RE. (D) Representative gating schematic for 
flow cytometry analysis. Gate 1 = Mononuclear cell population as determined by forward 
scatter (FSC) and side scatter (SSC) size relationship; Gate 2 = Selection of single cells 
from Gate 1 to exclude cell doublets or clumping; Gate 3 = Exclusion (~99%) of any 
CD31+/CD45+ expressing single cells (Lineage-/Lin- population) using fluorescence 
minus one (FMO) gating; Gating of cells from the Lin- population expressing NG2+, 
CD146+, or PDGFRα+. (E) Marker expression as a percentage of gated single cells 
extracted from Mobile and Stapled TAs after IM or RE excluding Lineage+ population. 
(F) Percentage of Lineage+ expression by each of the perivascular stem/stromal cell 
markers after IM or RE. (G) Percentage of NG2+Lin- pericytes co-expressing CD146 
and (H) the percentage of CD146+Lin- co-expressing NG2 in both Mobile and Stapled 
TAs after IM or RE. For (A) and (B) connected circles represent the immobilized and 
contralateral limbs from an individual sample. (C) Each data point equals one mouse. 
*p<0.05, difference between Stapled and Mobile (with paired t-test). Data are mean ± 









































Figure 3.2. The pericyte gene expression profile is similar between limbs 
following remobilization. (A) Absolute and (B) relative TA weights are significantly 
reduced following remobilization in mice used for either NG2+Lin- or CD146+Lin- pericyte 
isolation and gene expression analysis (connected circles represent the immobilized 
and contralateral limbs from an individual sample). (C) The paired difference between 
limbs (Stapled–Mobile) is not significantly different in mice used for either population. 
The relative difference in mRNA expression of growth and vascularization factors 
(GF/VAS), myogenic factors (MYO), extracellular matrix remodeling factors (ECM), and 
neurotrophic factors (NEURO) between Stapled and Mobile TAs for both (D) NG2+Lin- 
and (E) CD146+Lin- pericyte populations. Each individual circle is the ΔΔCt value 
calculated for one mouse (ΔCt Stapled–ΔCt Mobile). *p<0.05, difference between 









































Figure 3.3. Transfected pericyte co-transplantation experimental design. (A) 
Experimental outline of immobilization and transfection procedures for NG2+Lin- and 
CD146+Lin- intramuscular transplantation using a low molecular weight RGD-alginate 
hydrogel. (B) Representative images of transfected pericytes. NG2+Lin- pericytes were 
transfected with a ZsGreen-N1 reporter plasmid and CD146+Lin- pericytes were 


























































Figure 3.4. Pericyte transplantation into atrophied muscle enhances skeletal 
myofiber regrowth during remobilization. (A) Absolute and (B) relative TA weight 
was not significantly different following transplantation of the control hydrogel (Hydrogel) 
or the pericyte-loaded hydrogel (Pericyte). (C) The paired difference between limbs 
(Stapled–Mobile) was also not different between treatment groups. (D) Global myofiber 
cross sectional area (CSA) was significantly reduced in the Stapled TA following 
immobilization in the Hydrogel group that was recovered with pericyte transplantation. 
(E) The paired difference in myofiber CSA was significantly different between control 
and treated groups. (F) Representative cross-section images of Stapled and Mobile TA 
muscle from both Hydrogel control and Pericyte treated groups. Dystrophin (Red) and 
DAPI (Blue) merged images at 20X (scale bar = 20 µm) magnification are illustrated. 
(G) Myofiber size distribution (% of total fibers) for Stapled and Mobile TAs from control 
and pericyte-treated mice. (H) The paired difference between limbs for each group 
comparing the percentage change (Stapled–Mobile) at each size range. For (A), (B), 
and (D) connected circles represent the immobilized and contralateral limbs from an 
individual sample. For (C) and (E) each data point equals one mouse. *p<0.05, 
difference between Stapled and Mobile (with paired t-test). #p<0.05, paired difference 
between Hydrogel and Pericyte (with independent samples t-test). Data are mean ± 



























































Figure 3.5. Pericyte transplantation does not impact extracellular matrix collagen 
deposition, inflammation, or de novo myogenesis. (A) and (B) Collagen type I 
content is not altered by remobilization or pericyte transplantation. (C) Representative 
cross-section images of Collagen Type I (Red) and DAPI (Blue) merged images at 20X 
(scale bar = 20 µm) magnification. (D) and (E) No increase in macrophage infiltration is 
observed with pericyte transplantation. (F) Representative cross-section images of 
CD11b (Green) and DAPI (Blue) merged images at 20X (scale bar = 20 µm) 
magnification. (G) and (H) No change to the percentage of fibers with centrally located 
nuclei (CLN) were observed after treatment. (I) and (J) the nuclei-to-fiber ratio remained 









































Figure 3.6. Skeletal muscle capillarization is improved following pericyte 
transplantation prior to hindlimb remobilization. (A) Representative cross-section 
images of CD31 (Green), Dystrophin (Red), and DAPI (Blue) merged images at 20X 
(scale bar = 20 µm) magnification. (B) Capillary-to-fiber (C/F) ratio is significantly 
reduced in the Stapled muscle of the Hydrogel control group. Pericyte transplantation 
leads to a recovery of the C/F ratio. (C) The paired limb difference between Hydrogel 
and Pericyte group is significantly different. (D) Pearson correlation between C/F ratio 
and myofiber CSA fold change (Stapled / Mobile) for Hydrogel and Pericyte groups. (E) 
Capillary density is significantly increased in the immobilized TA with pericyte 
transplantation. (F) The paired limb difference demonstrates a significant increase in 
capillary density in the Pericyte group. (G) Pearson correlation between capillary density 
and myofiber CSA fold change (Stapled / Mobile) for Hydrogel and Pericyte groups. For 
(B) and (E) connected circles represent the immobilized and contralateral limbs from an 
individual sample. For (C), (D), (F), and (G) each data point equals one mouse. *p<0.05, 
difference between Stapled and Mobile (with paired t-test). #p<0.05, paired difference 
between Hydrogel and Pericyte (with independent samples t-test). Data are mean ± 























































Figure 3.7. Differential pericyte localization is observed following transplantation 
into atrophied skeletal muscle. (A) Cross-section image of DAPI (Blue), ZsGreen 
(Green), Laminin α-2 (Red), and merged image illustrating localization of transplanted 
NG2+Lin- pericytes following remobilization. (B) Cross-section image of DAPI (Blue), 
DsRed (Red), Laminin α-2 (Green), and merged image illustrating localization of 
transplanted CD146+Lin- pericytes following remobilization. Images at 20X (scale bar = 









































Supplementary Table 3.1 
 
Gene ID (Alias) Assay ID 
Angiogenin (Ang) Mm00833184_s1 
Endothelial growth factor (Egf) Mm00438696_m1 
Growth differentiation factor 11 (Gdf11) Mm01159973_m1 
Hepatocyte growth factor (Hgf) Mm01135184_m1 
Insulin-like growth factor 1 (Igf1) Mm00439560_m1 
Insulin-like growth factor 2 (Igf2) Mm00439564_m1 
Leukemia inhibitory factor (Lif) Mm00434762_g1 
Vascular endothelial growth factor A (Vegfa) Mm00437306_m1 
Myogenic factor 5 (Myf5) Mm00435125_m1 
Myogenic differentiation 1 (Myod) Mm00440387_m1 
Myogenin (Myog) Mm00446194_m1 
Paired box 7 (Pax7) Mm01354484_m1 
Collagen, type 1, alpha 1 (Col1a1) Mm00801666_g1 
Collagen, type III, alpha 1 (Col3a1) Mm01254476_m1 
Collagen, type VI, alpha 3 (Col6a3) Mm00711678_m1 
Matrix metalloproteinase 2 (Mmp2) Mm00439498_m1 
Matrix metalloproteinase 9 (Mmp9) Mm00442991_m1 
Matrix metalloproteinase 14 (Mmp14) Mm00485054_m1 
Transforming growth factor, beta 1 (Tgfb) Mm01178820_m1 
Tissue inhibitor of metallopeptidase 2 (Timp2) Mm00441825_m1 
Brain derived neurotrophic factor (Bdnf) Mm04230607_s1 
Fibronectin type III domain containing 5 (Fndc5) Mm01181543_m1 
Nerve growth factor (Ngf) Mm00443039_m1 
Neurotrophin 3 (Ntf3) Mm00435413_s1 
Tumor necrosis factor alpha (Tnfa) Mm00443258_m1 
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CONCLUSIONS AND FUTURE DIRECTIONS 
 The primary goal of this work was to determine the therapeutic potential of 
skeletal muscle-derived pericytes in the treatment of disuse atrophy. Specifically, we set 
out to evaluate the response of two distinct pericyte populations, NG2+Lin- and 
CD146+Lin-, to immobilization and subsequent remobilization, as well as to assess their 
ability to improve the recovery process following disuse atrophy. Interestingly, pericyte 
quantity is reduced with immobilization and transplantation positively impacts muscle 
capillarization and growth following disuse. 
 In conclusion, pericytes appear to have the capacity to beneficially improve 
skeletal muscle microvasculature and morphology. Therefore, we believe these findings 
provide sufficient justification for further development of a pericyte-specific therapy. 
 
 Future research is needed to address the following questions: 
1. Pericyte gene expression did not appear to be altered at the end of the 
remobilization period compared to contralateral controls. Since paracrine 
factor secretion likely underlies pericyte-mediated regrowth, earlier time 
points following remobilization should be evaluated. Once the optimal time 
point for differential gene expression is identified, deep RNA sequencing 
should be completed to generate a better understanding of all proteins and 
small non-coding RNAs that may be involved in recovery process.  
2. Co-transplantation of NG2+Lin- and CD146+Lin- pericytes resulted in improved 
skeletal muscle recovery post-disuse. However, the individual contribution of 
	91	
these different populations remains unknown. Assessing the impact of 
transplantation of populations separately will help to delineate the therapeutic 
potential of each pericyte population for further research. 
3.  Aged skeletal muscle demonstrates significant physiological differences 
compared to young/adult populations. What differences in pericyte quantity 
and function would be observed in aged mice following immobilization and 
remobilization? Additionally, aged individuals are less responsive to the 
traditional therapies utilized post-disuse. Would aged muscle be more or less 
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A.1 Abstract 
 β-hydroxy β-methylbutyrate (HMB) is a metabolite of the essential amino acid 
leucine. Recent studies demonstrate a decline in plasma HMB concentrations in 
humans across the lifespan, and HMB supplementation may be able to preserve muscle 
mass and strength in older adults.  However, the impact of HMB supplementation on 
hippocampal neurogenesis and cognition remains largely unexplored.  The purpose of 
this study was to simultaneously evaluate the impact of HMB on muscle strength, 
neurogenesis and cognition in young and aged mice. In addition, we evaluated the 
influence of HMB on muscle-resident mesenchymal stem/stromal cell (Sca-1+CD45-; 
mMSC) function to address these cells potential to regulate physiological outcomes. 
Three month-old (n=20) and 24 month-old (n=18) female C57BL/6 mice were provided 
with either Ca-HMB or Ca-Lactate in a sucrose solution twice per day for 5.5 weeks at a 
dose of 450 mg/kg body weight. Significant decreases in relative peak and mean force, 
balance, and neurogenesis were observed in aged mice compared to young (age main 
effects, p≤0.05). Short-term HMB supplementation did not alter activity, balance, 
neurogenesis, or cognitive function in young or aged mice, yet HMB preserved relative 
peak force in aged mice. mMSC gene expression was significantly reduced with age, 
but HMB supplementation was able to recover expression of select growth factors 
known to stimulate muscle repair (HGF, LIF). Overall, our findings demonstrate that 
while short-term HMB supplementation does not appear to affect neurogenesis or 
cognitive function in young or aged mice, HMB may maintain muscle strength in aged 
mice in a manner dependent on mMSC function.    
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A.2 Introduction 
 Cognitive impairment is frequently observed in older adults, and the occurrence 
of neurodegenerative disease increases dramatically with age. As of 2010, 
approximately 2.3 million people between the ages of 75-84 are estimated to suffer from 
Alzheimer’s Disease with that number expected to double by 2030 (Hebert et al., 2013). 
The mechanisms behind age-related cognitive impairment are varied including 
increased neuroinflammation, significant reductions to hippocampal volume, and a lack 
of new neuron formation in late adulthood (Barrientos et al., 2010; Kuhn et al., 1996; 
Lucassen et al., 2010; Wynne et al., 2009).  Concurrent with neurodegeneration is a 
substantial age-related loss of skeletal muscle mass and strength (sarcopenia), which is 
estimated to affect upwards of 50% of individuals 80 years or older (von Haehling et al., 
2010). The onset of these physical and cognitive impairments with age can significantly 
decrease an individual’s independence and quality of life (Janssen et al., 2004). 
Therefore, novel rehabilitation or nutritional strategies must be identified and 
implemented to treat and prevent age-related disabilities.     
 β-hydroxy β-methylbutyrate (HMB), a metabolite of the essential amino acid 
leucine, can attenuate the loss of skeletal muscle mass associated with prolonged 
bedrest or immobilization in older adults and aged rats (Alway et al., 2013; Deutz et al., 
2013). HMB also prevents dexamethasone-induced myotube atrophy in vitro (Aversa et 
al., 2012) as well as attenuates the decrease in protein synthesis observed with cancer 
cachexia in mice (Eley et al., 2007). HMB supplementation can preserve lean body 
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mass and improve muscle function in both older adults and aged rodents (Stout et al., 
2013; Vallejo et al., 2016; Vukovich et al., 2001; Wilson et al., 2012; Wilson et al., 
2014). Overall, the majority of studies suggest at least some benefits of HMB 
supplementation in the preservation of muscle function and/or lean body mass across 
the lifespan (Rowlands and Thomson, 2009; Wu et al., 2015). While the impact of HMB 
on skeletal muscle is most often investigated, minimal information exists regarding the 
effect of HMB on neurogenesis and cognition. Recently Salto et al. (2015) demonstrated 
the ability for HMB to increase neurite outgrowth in mouse neuroblastoma Neuro2a cells 
in vitro, and work by Kougias et al. (2016) demonstrated that long-term HMB 
supplementation preserves basilar dendritic size in the medial prefrontal cortex of aged 
rats, which may account for improvements in working memory (Hankosky et al., 2016). 
Further studies are necessary to investigate the impact of HMB supplementation on 
cognitive function in the context of aging, particularly given recent results that 
demonstrate a decline in endogenous plasma HMB concentration with age (Shreeram 
et al., 2016). 
 Mesenchymal stem/stromal cells (MSCs) reside in the interstitum of multiple 
tissues throughout the body, including skeletal muscle. Our lab has identified a specific 
mononuclear cell fraction in muscle (Sca-1+CD45-) that possess an MSC signature 
(CD90+CD105+CD31-CD34-) as well as a capacity for multi-lineage differentiation 
(Valero et al., 2012). MSCs derived from muscle (mMSCs) are largely non-myogenic 
based on a lack of expression for Pax7, MyoD, and Myf5, and provide an important 
stromal role in satellite cell activation and myofiber repair (Valero et al., 2012; Zou et al., 
2015). Despite the established role for mMSCs in the positive regulation of muscle 
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repair and function in young mice, minimal information exists with regard to mMSC 
stromal capacity in aged mice. Our lab recently demonstrated that collagen significantly 
reduces mMSC capacity for growth factor synthesis and satellite cell activation in vitro 
(De Lisio et al., 2014). Therefore, it is reasonable to speculate that mMSC function may 
be compromised as a result of the collagen accumulation observed in the aged skeletal 
muscle niche (Alnaqeeb et al., 1984), and that these events may adversely impact the 
capacity for aged skeletal muscle to repair and grow in response to physiological 
stimuli. 
 The purpose of the current study was to simultaneously evaluate the impact of 
HMB supplementation on muscle strength, neurogenesis, and cognition in young and 
aged mice.  The specific impact of HMB on mMSC function was assessed both in vivo 
and in vitro. We hypothesized that HMB would beneficially impact both muscle strength 
and cognition in mice, and that the observed changes would correlate with 











A.3 Methods  
Animals 
 Three month-old (Young) and 24 month-old (Aged) female C57BL/6 mice were 
obtained from Charles River and the National Institute on Aging (NIA), respectively. 
Animals were fed standard laboratory chow and had access to water ad libitum. Animals 
were housed in pairs (2 mice per cage) in a pathogen-free animal room under controlled 
conditions (12-hour light/dark cycle, 25°C). Animal use protocols were approved by the 
Institutional Animal Care and Use Committee (IACUC) at the University of Illinois at 
Urbana-Champaign, and all National Institute of Health guidelines for the care and use 
of animals were followed.   
 
HMB supplementation 
 The experimental group was supplemented with a 10% sucrose solution 
containing Ca-HMB (Abbott Industries, Champaign, IL). The control group was 
supplemented with a 10% sucrose solution containing an equal concentration of calcium 
in the form of Ca-Lactate (Fisher Scientific, Pittsburgh, PA). Supplementation occurred 
twice per day (at the beginning and end of the light cycle) for approximately 5.5 weeks. 
A 5.5 week experimental duration was chosen in order to accommodate the time frame 
for new neuron formation and integration within the adult brain (Aimone et al., 2104), 
allowing for simultaneous evaluation of the impact of HMB supplementation on 
neurogenesis, cognition, and skeletal muscle function. Animals received an appropriate 
volume of solution for a final dosing concentration of 450 mg/kg body weight/dose of 
Ca-HMB or Ca-Lactate (Baxter et al., 2005; Wilson et al., 2012). The solution was 
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delivered via a modified 10 mL serological pipette fitted with a double ball bearing sipper 
tube, as described previously (Bulwa et al., 2011). Mice were divided into four groups 
based on body weight prior to the start of the experiment: Young+Control (Y+C, n=10), 
Young+HMB (Y+H, n=10), Aged+Control (A+C, n=9), Aged+HMB (A+H, n=9).  
 
Body weight and grip strength measures  
 Each animal was weighed prior to the experiment and weight was recorded 
weekly thereafter. Four-limb grip strength was measured weekly using a Digital Grip 
Strength Meter (Columbus Instruments, Columbus, OH). For grip strength measures, 
mice were placed upon a metal mesh grid connected to a force transducer and were 
allowed to grip with all four limbs. After gripping was confirmed, the researcher gently 
pulled the mouse’s tail posteriorly, parallel to the grid at a constant rate until volitional 
release. Force was recorded (gram-force) for three trials. Weight measures obtained 
immediately after each test was used to express peak and mean grip strength relative to 
weight (gram force (g)/ gram body weight (g)). The same tester performed all trials. 
 
Home cage activity monitoring  
 As described previously (Zombeck et al., 2011), animals were transferred from 
their regular housing into clear acrylic areas (18.5 x 33.5 x 16.0 cm) covered with a 
clear lid for video tracking over 5 days. Food and water was provided on the side of the 
cages to allow the mouse to remain visible in all areas of the cage. Ceiling mounted 
video cameras interfaced with two computers using TopScan video tracking software 
(Clever Sys Inc., Reston, VA), and continuously monitored the distance traveled within 
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the cage (red light was used during the dark cycle for continuous video tracking). Total 
distance (meters) traveled per day was recorded.  
 
Rotarod 
 An automated rotarod unit (AccuRotor RotaRod Tall Unit, 63cm fall height, 30mm 
diameter rotating dowel; Accuscan, Columbus, OH) was used to assess balance and 
coordination. Mice were placed on the stationary dowel which then began acceleration 
at a rate of 60 rpm/min. Latency to fall was recorded using a photobeam which stopped 
the timer automatically when the falling mouse broke the plane of the photobeam. Each 
mouse performed four consecutive trials for three consecutive days. 
 
Novel object recognition  
 Mice were placed in the testing arena (50 x 38 x 20 cm) for 10 minutes of 
habituation on Day 1. On Day 2, mice were placed in the arena with two identical 
objects and allowed to explore the objects for 30 seconds before being returned to their 
home cages. On Day 3, mice were placed in the arena with one familiar object and one 
completely novel object. The mice had 5 minutes to explore the arena. Mice were video 
monitored using TopScan software to measure time spent sniffing each object.  
 
Passive avoidance  
 On Day 1 (acquisition), mice were placed in the illuminated compartment of a 
GeminiTM Avoidance System (SD Instruments, San Diego, CA) and allowed to explore 
both illuminated and non-illuminated compartments via a raised guillotine door. Once 
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the animal completely entered the non-illuminated compartment, the door was 
automatically closed and an electric foot shock was delivered (0.5 mA, 4 second 
duration). After 10 seconds, the chamber was illuminated and the guillotine door was 
raised allowing the mouse access to the non-illuminated chamber. Trials continue until 
the animal avoids the non-illuminated compartment for 120 seconds. On Day 2 
(retention), mice were placed in the illuminated compartment and the latency time for 
entering the non-illuminated compartment was recorded (maximum latency time of 300 
seconds). 
 
Tissue collection and preservation  
 Prior to euthanasia, puromycin dihydrochloride (EMD Millipore, Billerica, MA) was 
injected intraperitoneally (0.04 µmol/gram body weight) to assess protein synthesis 
(Goodman et al., 2011; Goodman and Hornberger, 2013). Thirty minutes post-injection, 
mice were fully anesthetized using isoflurane, and gastrocnemius-soleus muscle 
complexes were excised and weighed. One complex was immediately frozen in 
precooled isopentane, while the other complex was immersed in 1x PBS plus 
penicillin/streptomycin, and used immediately for mMSC isolation. Following excision of 
gastrocnemius-soleus complexes, animals were taken off isoflurane and anesthetized 
with 200mg sodium pentobarbital/kg body weight. Brains were subsequently perfused 
transcardially with 4% paraformaldehyde in 1x PBS and fixed overnight. Fixed brains 




Sca-1+CD45- cell isolation and FACS 
 Sca-1+CD45- cell isolation was performed as previously described (Huntsman et 
al., 2013; Valero et al., 2012). Briefly, muscle tissue was minced and enzymatically 
digested for 45-60 minutes at 37°C. The enzyme solution consisted of 0.2-0.3% 
collagenase Type 2 (Worthington, Biochemical Corp., Lakewood, NJ), 60 U/mL DNase 
(Sigma-Aldrich, St. Louis, MO) and 2.5 mM CaCl2 in a 1x PBS solution. Mononuclear 
cells were isolated via filtration using 70 µm filters (Fisher Scientific). Filtered samples 
were then incubated for 10 minutes on ice with anti-mouse CD16/CD32 (eBioscience, 
San Diego, CA) to block Fc-mediated nonspecific interactions. Following blocking, cells 
were incubated with a mix of monoclonal anti-mouse antibodies, Sca-1-phyocerythrin 
(PE) and CD45-allophycoctanin (APC) (anti-Sca-1-PE, 600 ng/106 cells and anti-CD45-
APC, 300 ng/106 cells, eBioscience), diluted in filtered 2% FBS in 1xPBS for 1 hour on 
ice. Following antibody staining, cells were washed in 2% FBS and filtered through a 40 
µm filter before fluorescence-activated cell sorting (FACS). Negative and single-stained 
controls were used to establish gates for FACS, which was performed using an iCyt 
Reflection System located at Carle Hospital’s Biomedical Research Center (Urbana, IL). 
Sca-1+CD45- cells were either collected in mMSC-specific growth media (high glucose 
Dulbecco’s Modified Eagle’s Medium (DMEM), 10% FBS, 5µg/mL gentamycin) for in 
vitro experiments or collected and lysed with Buffer RLT (Qiagen, Valencia, CA). Lysed 
samples were stored at -80° to be analyzed for relative mRNA expression.  
 
In vitro incubation of MSCs with HMB 
 Sca-1+CD45- cells were extracted and sorted (as described above) from 5 week-
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old SJL/C57BL6 mixed background wild-type mice from our own breeding colony. Post-
sorting, cells were seeded on culture dishes (2.5x104 cells/cm2) and incubated at 37oC 
and 5% CO2 with growth media which was changed every 3-4 days. Upon reaching 
confluency, cells were dissociated using Accutase (Thermo Fisher, Waltham, MA), then 
seeded on 6-well plates at a density of 100,000 cells/well. Once confluent, cells were 
incubated with serum-free growth media (DMEM) for 3 hours. Media was removed and 
cells were incubated with 0, 50, or 100 µg HMB/mL DMEM for 3 hours. HMB was 
supplied in the form of β-hydroxisovaleric acid from Sigma Aldrich (Saint Louis, MO). At 
the end of each time point, cells were lysed with Buffer RLT (Qiagen) and lysates were 
snap frozen in liquid nitrogen to be analyzed for relative mRNA expression.  
 
RNA isolation and cDNA synthesis  
 RNA was extracted from cell lysates using RNeasy Micro Kit (Qiagen), following 
the manufacturer’s instruction. Quantity of isolated RNA was assessed in duplicate on a 
Take-3 application plate using a Synergy H1 Hybrid Multi-Mode Microplate Reader 
(BioTek, Winooski, VT). Starting RNA concentration of at least 15ng (and up to 250ng) 
was used to perform reverse transcription via the High Capacity cDNA Reverse 
Transcription Kit (Life Technologies, Grand Island, NY) per manufacturer’s instructions.  
 
High throughput microfluidics qPCR using Fluidigm BiomarkTM HD 
 High throughput microfluidic quantitative PCR (qPCR) of synthesized cDNA was 
ran on a 96x96 Dynamic Array Integrated Fluidic Circuit (IFC) (Fluidigm, San Francisco, 
CA) by the Functional Genomics Unit at the Roy J. Carver Biotechnology Center 
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(Urbana, IL). This qPCR system results in a more accurate and repeatable analysis of 
multiple genes within multiple samples (up to 96 genes analyzed in up to 96 samples). 
Diluted cDNA samples and primers were mixed together on a Dynamic Array Chip using 
the IFC system. The chip was then loaded into the Fluidigm BiomarkTM HD for qPCR 
analysis. Hypoxanthine guanine phosphoribosyl transferase (HPRT) was used as the 
housekeeping gene, and relative mRNA expression was expressed relative to the Y+C 
group using the ΔΔCt method.  
 
cDNA preamplification and quantitative PCR 
 Preamplification of cDNA was completed using TaqMan PreAmp Master Mix Kit 
(Life Technologies). The primer pool was composed of inventoried TaqMan primers, 
which were diluted in Tris-EDTA buffer to a final concentration of 0.2X. PreAmp reagent 
was mixed with the primer pool and sample cDNA in a thin-walled 0.2 mL PCR tube. 
Each reaction was amplified for 14 cycles using a thermocycler (ABI Geneamp 9700, 
Life Technologies) and then diluted in diethylpyrocarbonate (DEPC) RNase-free water. 
qPCR was performed using the 7900HT Fast Real-Time PCR System with TaqMan 
Universal PCR Master Mix (Applied Biosystems, Grand Island, NY). All genes were 
normalized to HPRT for in vivo analyses or glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH) for in vitro analyses, and expressed relative to corresponding 
control condition.  Gene expression data are presented using the ΔΔCt method with 
cycle threshold (Ct) replicate values within 0.5 Ct units. Inventoried TaqMan primers 
were purchased from Applied Biosystems. Primer information and gene expression 
assay ID numbers used in this study are provided in Supplementary Table A.1. 
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Evaluation of protein expression 
 Muscle protein was manually homogenized in ice-cold Triton X extraction buffer 
(20mM Hepes, 2mM EGTA, 50mM β-glycerophosphate, 1mM dithiothreitol (DTT), 1mM 
sodium vanadate, 1% Triton X-100, 10% Glycerol) supplemented with 10 µM leupeptin, 
3mM benzamidine, 5 µm pepstatin A, 10 µg/mL aprotinin, and 1mM 
phenylmethylsulfonyl fluoride (PMSF). The homogenate solution was further disrupted 
by occasional vortexing for 30 minutes on ice. Samples were then centrifuged at 15000 
RPM for 15 minutes at 4oC, and the supernatant was removed.  Protein concentrations 
were quantified using the Bradford protein array with bovine serum albumin (BSA) used 
for the standard curve. Equal amounts of protein (30-50 µg) were separated by SDS-
PAGE using 8-10% acrylamide gels and transferred onto nitrocellulose membranes. 
Ponceau S staining was used to verify equal loading of protein. Membranes were 
blocked in Tris-buffered saline (pH 7.8) with 0.1% Tween-20 (TBS-T) containing 5% 
BSA for 1 hour, and incubated overnight at 4oC with the following primary antibodies 
purchased from Cell Signaling Technology (Beverly, MA): phospho-AktSer473 (#4058S), 
Akt (#9272S), phospho-mTORSer2448 (#2971), mTOR (#2972), phospho-p70S6 
KinaseThr389 (#9205), p70S6 Kinase (#9202). Following overnight incubation, 
membranes were rinsed with TBS-T and incubated for 1 hour with horseradish 
peroxidase-conjugated anti-rabbit secondary antibodies (Cell Signaling Technologies, 
Inc., Beverly, MA). Bands were detected using SuperSignal West Femto Maximum 
Sensitivity Substrate (Thermo-Scientific, Rockford, IL) and a Bio-Rad ChemiDoc XRS 
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system (Bio-Rad, Hercules, CA). Quantity One software (Bio-Rad) was used to 
complete the quantification of bands. 
 
Immunohistochemistry 
 Perfused brain were sectioned by cryostat into 40 µm-thick coronal sections and 
stored in 24-well plates containing tissue cryoprotectant (30% ethylene glycol, 25% 
glycerin, 45% PBS) at -20°C. To identify immature neurons within the granular layer of 
the dentate gyrus, a one-in-six- series of rostral to caudal sections (separated by 240 
µm increments) from each mouse were stained for DCX-DAB. Briefly, free-floating 
sections were treated with goat anti-DCX (1:1000, Santa Cruz Biotechnology, TX) 
primary antibody for 48 hours at 4°C. Following primary antibody incubation, sections 
were then incubated in biotinylated secondary antibody donkey anti-goat (1:200, Santa 
Cruz Biotechnology, TX) for 90 minutes. Post-secondary incubation, sections were 
washed and then treated with the ABC system for 60 minutes (Vector Laboratories, 
Burlingame, CA) and stained with a DAB kit (Sigma Aldrich). DCX-DAB images were 
acquired using a Zeiss AxioCam digital camera and Axiovision software (Zeiss, 
Thornwood, NY). To evaluate neurogenesis, the total number of DCX+ cells per coronal 
section of the granular layer of the dentate gyrus was calculated using ImageJ software. 
 
Statistical analysis 
 All data is presented as mean ± SEM. Two-way ANOVA followed by LSD post-
hoc analysis was performed to determine HMB x Age interactions and main effects of 
age or HMB for all in vivo measures. Weekly grip strength and daily activity monitoring 
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measures were assessed using repeated measures ANOVA followed by LSD post-hoc 
analysis. Spearman’s rho was used to determine the correlation between gene 
expression/relative muscle weight and grip strength in vivo. For in vitro experiments, 
one-way ANOVA followed by LSD post-hoc analysis was used to determine HMB main 
effects on mMSC gene expression. Data was transformed to correct non-normal data 
when appropriate. All statistical analyses were performed with SPSS Ver. 22 (IBM, 


















A.4 Results  
Effect of HMB and age on body weight, muscle weight, and grip strength 
 Body weight was increased in aged mice compared to young (age main effect, 
p<0.01) with no effect of HMB on body weight in young or aged cohorts (Figure 1A).  
Absolute (data not shown) and relative gastrocnemius-soleus muscle weight was not 
affected by age or HMB supplementation (Figure 1B). Relative peak grip strength 
showed a significant Time x Age interaction over the course of the study (p=0.04) 
(Figure 1C). Relative peak grip strength was significantly reduced in aged mice 
compared to young (age main effect, p<0.001), but HMB prevented this reduction in 
relative peak force after 5.5 weeks of supplementation (p=0.05) (Figure 1D). Relative 
mean grip strength demonstrated a significant Time x Age (p=0.03) and Time x HMB 
interaction (p=0.05) (Figure 1E). Relative mean grip strength was significantly reduced 
with age (age main effect, p<0.05) and a trend was observed for HMB to increase mean 
force at the end of the supplementation period (p=0.06) (Figure 1F). The hypertrophic 
signaling pathway, including AKT (Figure 2A), mTOR (Figure 2B), and p70S6K (Figure 
2C) phosphorylation, total protein, and the subsequent ratio was evaluated, but no 
differences were detected between groups. Similarly, no changes in puromycin 
incorporation were observed with age or HMB supplementation (data not shown). 
 
Effect of HMB on cognitive function in aged mice  
 The experimental design for supplementation and behavioral testing is presented 
in Figure 3A. After 2 weeks of HMB supplementation, cognitive testing began and lasted 
for approximately 3.5 weeks with continued supplementation. To assess physical 
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activity, locomotion was tracked daily over 5 days. The total distance traveled each day 
was not significantly different between groups (Figure 3B). Cerebellar control of 
muscular balance and coordination was assessed using rotarod testing. The average 
time spent on the rotarod over the 3 days of testing was significantly reduced with age 
(age main effect, p<0.05) and no recovery was observed with HMB supplementation 
(Figure 3C). Neither fear-conditioned learning (passive avoidance) nor recognition-
based learning (novel object recognition) was altered by age or HMB supplementation. 
Latency to cross during the passive avoidance test and percent time with novel object 
during the novel object test were unaffected by age or treatment (Figures 3D-E). The 
total number of newly formed (immature) neurons, as measured by doublecortin positive 
(DCX+) cells, was significantly reduced in the dentate gyrus of the hippocampus with 
age (age main effect, p<0.05), but not affected by HMB (Figure 3F). 
 
mMSC function is blunted with age and partially restored with HMB supplementation 
 mMSC gene expression was evaluated using a Fluidigm system (37 genes). 
Table 1 presents mMSC relative mRNA expression in all groups and the respective 
statistical results. Cell surface marker gene expression was altered such that CD90 
(MSC) and neural-glial antigen 2 (NG2; pericyte), gene expression was decreased with 
age, but HMB had no effect on relative expression. Additionally, a trend towards a 
decrease in platelet-derived growth factor α (PDGFRα) expression was noted with age 
(p=0.07). Growth and neurotrophic factor gene expression was significantly 
downregulated with age, specifically the expression of LIF, HGF, IGF-1, VEGFa, EGF, 
BDNF, NGF, and FNDC5. Interestingly, an Age x HMB interaction was detected for 
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HGF (p=0.02), and HMB recovered LIF and HGF gene expression in aged mice. 
Several factors associated with remodeling of the extracellular matrix were also 
downregulated with age, including matrix metalloproteinase 2 and 14 (MMP-2 and 
MMP-14), collagen type I alpha-1 (Col1α1), plasminogen activator inhibitor-1 (PAI-1), 
and fibroblast-specific protein 1 (FSP-1), none of which were recovered with HMB. Lysyl 
oxidase (LOX) gene expression was increased with HMB supplementation in both 
young and aged mice. The proinflammatory cytokine tumor necrosis factor alpha 
(TNFα) gene expression was increased with age, while the anti-inflammatory protein 
RPL13a (Basu et al., 2014) was reduced with age.  
A significant correlation was detected between relative peak force and HGF gene 
expression (r=0.46, p=0.02), but no correlation was observed between relative peak 
force and LIF gene expression (r=0.20, p=0.35) nor relative peak force and relative 
muscle weight (r=0.08, p=0.63). 
 
HMB alters the mMSC gene expression profile in vitro. 
 mMSCs isolated from skeletal muscle of young mice were incubated with HMB in 
vitro to determine the immediate response to HMB exposure. Thirty-five different genes 
were evaluated and data are presented based on relevance to in vivo results (LIF, HGF, 
NGF) and/or putative involvement in muscle health (nerve repair, vascularization, 
immune function). LIF expression was significantly decreased with direct exposure to 
HMB (p<0.001), whereas HGF and NGF remained unaltered (Figures 4A-C). Relative 
mRNA expression of EGF and neurotrophin-3 (NTF-3) was increased with HMB 
treatment in vitro (p<0.002 and p<0.01, respectively) (Figures 4D-E), while the 
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expression of angiogenin appeared to increase in a dose-dependent manner (not 
statistically significant) (Figure 4F). In contrast to in vivo results, CCL2 gene expression 
was significantly decreased with HMB (p<0.01), and a trend toward a decrease was 





















A.5 Discussion  
 The purpose of the current study was to evaluate the impact of HMB 
supplementation on muscle strength, neurogenesis, and cognition in young and aged 
mice. Reductions in strength, balance, and neurogenesis were detected in aged mice 
compared to young; however, the behavioral tests performed to evaluate cognition did 
not reveal any age-related impairments. While HMB supplementation did not provide 
any benefit to young mice nor mitigate the age-related declines in balance or 
neurogenesis, HMB did attenuate the small, but significant reduction to relative peak 
force observed in aged mice.  Given the potential for muscle resident stem/stromal cells 
(mMSCs) to influence skeletal muscle repair and function (Huntsman et al., 2013; 
Valero et al., 2013; Zou et al., 2015), we evaluated the effect of HMB on mMSC gene 
expression both in vivo and in vitro. We demonstrate for the first time that mMSC gene 
expression is altered with age in a manner that suggests a marked decline in the ability 
for mMSCs to synthesize factors necessary to support skeletal muscle repair, 
maintenance, and turnover in aged mice. HMB supplementation did not substantially 
reverse the age-related changes to mMSC gene expression. However, preservation of 
LIF and HGF gene expression, as well as a positive correlation between HGF 
expression and relative peak force in aged mice supplemented with HMB, suggest the 
potential for HMB to improve nerve function or prime the muscle for repair in the event 
of injury. Thus, this data provide evidence of a novel role for mMSCs in initiating the 
health benefits of HMB.  
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HMB preserves skeletal muscle strength in aged mice independent of muscle weight or 
hypertrophic signaling 
 HMB can positively alter body composition and augment strength in humans 
when administered in combination with resistance exercise (Gallagher et al., 2000; 
Wilson et al., 2014). Our findings indicate that in the absence of any external stimulus 
(e.g. exercise, skeletal muscle atrophy), HMB does not significantly influence body or 
muscle weight in young or aged mice. Similarly, no changes in hypertrophic signaling 
were detected with age or HMB supplementation. These findings partially conflict with 
findings from Pimentel et al. (2011), who demonstrated an increase in p70S6K 
phosphorylation and total mTOR in the extensor digitorum longus muscle of adult male 
Wistar rats after one month of HMB supplementation. However, no increase in mTOR 
phosphorylation was reported, nor was there any changes to total or phosphorylated 
AKT protein. Despite the fact that hypertrophic signaling and muscle weight were not 
altered, relative peak and mean force were decreased with age, and HMB 
supplementation was able to prevent this reduction in relative peak force. Thus, short-
term HMB supplementation may enhance strength in aged mice independent of 
changes to skeletal muscle mass. In support of this hypothesis, Vallejo et al. (2016) 
reported a similar improvement in peak force without any change to muscle mass 
following 8 weeks of HMB supplementation in aged mice (22 months). Similar 
improvements in tetanic force were observed in young rats with 4 weeks of 
supplementation (Da Justa Pinheiro et al., 2012). Future studies should investigate the 
impact of HMB on peripheral nerve structure and/or function in order to account for 
these strength changes.   
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HMB fails to improve cognition or enhance neurogenesis in aged mice. 
Santos-Fandila et al. (2014) verified the presence of HMB in the hippocampus 
following oral supplementation in Sprague-Dawley rats, but the extent to which HMB 
can directly or indirectly impact hippocampal neurogenesis and cognition is largely 
unknown. In the current study, significant reductions in balance and neurogenesis were 
detected in aged mice compared to young, yet our behavioral assessments failed to 
demonstrate any reduction in performance. In the limited studies that have evaluated 
the impact of HMB or other nutritional supplements on uncomplicated aging in the 
rodent model, most do not demonstrate any improvement to cognition when treatment 
begins at an advanced age (Gibbons et al., 2014; Russ et al., 2015). In contrast, 
preservation of prefrontal cortex structure and working memory can be observed when 
treatment begins in middle age and is extended into old age (Hankosky et al., 2016; 
Kougias et al., 2016). Thus, future work should determine the extent to which long-term 
HMB supplementation can prevent declines in neuroplasticity and cognitive function 
across the lifespan.  
 
HMB selectively restores mMSC function in aged mice 
 Previous studies have demonstrated the ability of HMB to alter the functional 
characteristics of different cell types in vitro, including myoblasts (Kornasio et al., 2008; 
Vallejo et al., 2016), myotubes (Aversa et al., 2012) and a neuroblastoma cell line, 
Neuro2a (Salto et al., 2015). In vivo, HMB supplementation can increase satellite cell 
proliferation in aged rat skeletal muscle during recovery from hindlimb suspension 
(Alway et al., 2013). These studies indicate some potential for HMB to directly stimulate 
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skeletal muscle stem cell expansion and neuronal elongation and branching. Our study 
is the first to investigate the effect of age and HMB on mMSC gene expression. With the 
use of a high throughput screening method, we were able to evaluate growth, 
neurotrophic, and immunomodulatory factor gene expression in mMSCs from young 
and aged mice. Interestingly, mMSC gene expression was significantly altered with age, 
such that age main effects were noted for inflammatory cytokines (TNFα, increased; 
RPL13a, decreased), several factors that regulate satellite cell activation and muscle 
repair (HGF, LIF, IGF-1, VEGFα; decreased), and factors that support the growth and 
survival of developing and mature neurons (EGF, BDNF, NGF, FNDC5; decreased). 
HMB was able to reverse the impact of age on HGF and LIF gene expression, and a 
positive correlation was detected between HGF gene expression and relative peak 
muscle force, suggesting some improvement in the capacity for muscle repair or 
function with short-term HMB supplementation (Hunt et al., 2012; Van Mater et al., 
2014). Altogether, these findings suggest that mMSC dysfunction in aged mice may 
contribute to the age-related declines in muscle function, and that HMB possesses the 
capacity to revitalize mMSC activity.  
 
mMSC function in vitro is enhanced with HMB treatment 
We intentionally chose a relatively short supplementation period to optimize the 
opportunity to observe changes in mMSC function with HMB treatment. The lack of a 
potent HMB effect on mMSC gene expression in young and aged mice suggests that 
there was either a selective effect of HMB on mesenchymal stem/stromal cell function 
or that the cells were no longer as responsive to supplementation after 5.5 weeks. To 
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address the mMSC response to HMB, an in vitro experiment was conducted to evaluate 
the early gene expression profile of mMSCs following HMB treatment.  At 3 hours post-
treatment, the cells were highly responsive to HMB. A decline in CCL2 (MCP-1) 
expression, as well as a trend towards a decrease in GM-CSF expression, suggest that 
HMB may alter mMSC stromal activity by inhibiting the recruitment of inflammatory cells 
to skeletal muscle, which would be beneficial in the case of aging when chronic 
inflammation is persistent. The relative expression of EGF, which can regulate neural 
stem cell function and increase neurogenesis (Jin et al., 2003; Sütterlin et al., 2013), 
and the expression of the neurotrophic factor, NTF-3, which can mediate neuronal 
differentiation and neurite outgrowth (Ammendrup-Johnsen et al., 2015; Oliveira et al., 
2013), were both significantly increased in a dose-dependent manner. However, BDNF, 
similarly characterized as a neurotrophic factor, was not altered in vitro (data not 
shown). Thus, results from in vivo and in vitro analyses suggest that a combination of 
mMSC-derived factors, including HGF, LIF, EGF and NTF-3, may contribute to 











 Overall, the results from this study suggest that short-term HMB supplementation 
can preserve strength in aged mice, yet deficits to balance and neurogenesis remain. 
Future studies are necessary to evaluate the impact of long-term HMB supplementation 
on the preservation of muscle-resident stromal cell function, strength, neurogenesis, 
and cognition with age. 
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Figure A.1. Acute HMB supplementation does not affect body or muscle weight, 
but restores grip strength in aged mice. Body weight was increased in aged mice 
after 5.5-weeks of supplementation with no increase in gastrocnemius-soleus muscle 
weight (A and B). Both relative peak and mean grip strength were reduced in aged mice 
compared to young mice with HMB supplementation preserving strength in aged mice 
(C-F). Values are mean ± SEM. *p<0.05, age main effect; §p<0.05 compared to all 


















































































Figure A.2. Hypertrophic signaling in young and aged mice is unaffected by HMB 
supplementation. Representative immunoblots and summary of data for phospho-
/total-Akt (A), mTOR (B), and p70S6K (C). All values are mean ± SEM. All proteins are 

































Figure A.3. HMB supplementation does not affect cognitive performance or 
neurogenesis in young or aged mice. Experimental design for HMB supplementation 
and behavioral assessments (A). Daily distance traveled was consistent between 
groups during supplementation as measured by home cage activity monitoring (B). 
Average time spent on rotarod over 3 days was decreased with age and not recovered 
with HMB. Neither fear-mediated learning nor was hippocampal-dependent learning 
different between groups (D and E). Total number of new neurons was significantly 
reduced in aged mice but not affected by HMB supplementation (F). Values are mean ± 




Gene Y + C Y + H A + C A + H Age effect HMB effect 
Cell surface markers    
Sca-1 1.13 ± 0.18 1.30 ± 0.18 1.23 ± 0.52 0.96 ± 0.34 0.16 0.98 
PDGFRα 1.18 ± 0.25 1.88 ± 0.38 1.22 ± 0.37 0.84 ± 0.14 0.07 0.43 
CD90 1.13 ± 0.20 1.93 ± 0.36 0.87 ± 0.23 0.84 ± 0.18 0.01 0.67 
PDGFRβ 1.06 ± 0.14 1.50 ± 0.27 1.39 ± 0.45 0.97 ± 0.24 0.24 0.74 
NG2 1.22 ± 0.30 1.26 ± 0.26 0.64 ± 0.28 0.74 ± 0.19 0.02 0.56 
CD146 1.46 ± 0.38 1.78 ± 0.49 1.79 ± 0.83 1.88 ± 0.81 0.84 0.61 
      
Growth factors     
LIF 1.22 ± 0.33 1.61 ± 0.42 0.40 ± 0.17* 1.09 ± 0.17 0.02 0.03 
HGF 1.51 ± 0.64 1.20 ± 0.23 0.29 ± 0.05* 0.97 ± 0.11 0.01 0.02 
FGF2 1.17 ± 0.21 1.49 ± 0.30 1.42 ± 0.74 1.37 ± 0.34 0.34 0.19 
IGF-1 1.09 ± 0.18 1.39 ± 0.27 0.82 ± 0.24 0.54 ± 0.08 0.01 0.72 
VEGFα 1.16 ± 0.23 1.40 ± 0.22 1.06 ± 0.48 0.35 ± 0.07 <0.001 0.41 
EGF 1.05 ± 0.14 0.91 ± 0.09 0.67 ± 0.10 0.81 ± 0.11 0.05 0.99 
Areg 1.34 ± 0.51 2.69 ± 1.47 1.11 ± 0.77 1.13 ± 0.53 0.16 0.47 
      
Neurotrophic factors     
BDNF 1.26 ± 0.46 0.84 ± 0.19 0.41 ± 0.08 0.59 ± 0.09 0.03 0.76 
NGF 1.28 ± 0.51 1.40 ± 0.40 0.20 ± 0.05 0.80 ± 0.31 0.03 0.11 
FNDC5 1.45 ± 0.47 1.46 ± 0.37 0.39 ± 0.14 0.36 ± 0.16 0.01 0.63 
     
Extracellular matrix remodeling   
MMP2 1.13 ± 0.20 1.50 ± 0.26 1.13 ± 0.45 0.65 ± 0.12 0.03 0.80 
MMP14 1.13 ± 0.19 1.10 ± 0.18 0.90 ± 0.37 0.66 ± 0.13 0.02 0.87 
       
Timp2 1.15 ± 0.24 1.64 ± 0.30 1.19 ± 0.53 0.81 ± 0.14 0.07 0.64 
Lama2 1.40 ± 0.27 1.97 ± 0.30 1.51 ± 0.50 0.92 ± 0.18 0.09 0.61 
Col1α1 1.10 ± 0.15 1.70 ± 0.29 0.48 ± 0.17 0.36 ± 0.10 <0.001 0.77 
TGFβ1 1.15 ± 0.22 1.49 ± 0.32 0.89 ± 0.20 0.97 ± 0.18 0.17 0.54 
CTGF 1.49 ± 0.51 1.83 ± 0.36 1.25 ± 0.38 1.15 ± 0.14 0.48 0.32 
LOX 1.08 ± 0.15 2.42 ± 0.51 1.56 ± 0.35 2.10 ± 0.37 0.62 0.03 
PAI-1 1.88 ± 0.84 1.72 ± 0.45 0.55 ± 0.13 0.49 ± 0.08 0.01 0.77 
Eng 1.12 ± 0.20 1.65 ± 0.33 1.45 ± 0.37 1.19 ± 0.18 0.75 0.52 
Ang 1.25 ± 0.27 2.63 ± 0.80 1.18 ± 0.41 1.42 ± 0.37 0.23 0.08 
FSP-1 1.39 ± 0.43 2.01 ± 0.55 0.56 ± 0.13 1.09 ± 0.23 0.03 0.07 
     
Inflammation and oxidative stress   
IL-15 1.18 ± 0.24 1.38 ± 0.39 1.37 ± 0.58 0.61 ± 0.07 0.16 0.71 
IL12b 1.11 ± 0.22 0.79 ± 0.34 1.16 ± 0.34 1.19 ± 0.60 0.70 0.25 
TNFα 1.28 ± 0.42 0.72 ± 0.07 1.66 ± 0.24 2.11 ± 0.35 <0.001 0.76 
CCL2 1.24 ± 0.29 2.31 ± 0.70 1.07 ± 0.14 1.80 ± 0.56 0.70 0.24 
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TLR4 1.50 ± 0.64 1.36 ± 0.25 1.14 ± 0.48 1.15 ± 0.28 0.48 0.85 
RPL13a 1.47 ± 0.61 2.80 ± 1.64 0.46 ± 0.30 0.36 ± 0.12 0.02 0.56 
Mt1 1.19 ± 0.26 4.54 ± 1.62 2.72 ± 1.15 1.23 ± 0.33 0.62 0.66 
Mt2 1.92 ± 0.59 2.41 ± 0.80 1.58 ± 0.88 0.93 ± 0.33 0.28 0.91 
* Significantly different vs. all other groups, p ≤ 0.05. 
 
 
Table A.1. HMB selectively recovers age-related decrease to mMSC relative 
mRNA expression. Gene expression of various MSC markers, growth and 
neurotrophic factors, factors associated with extracellular remodeling, and inflammatory 
cytokines for each group are presented as mean ± SEM. Age and HMB main effects 
were considered significant at p≤0.05 and are in bold. *Significantly different vs. all other 























































Figure A.4. Isolated mMSCs treated with HMB in vitro demonstrate an altered 
gene expression profile. Relative mRNA expression of factors associated with growth 
(A, B, and C), neurogenesis (D and E), angiogenesis (F), and inflammation (G and H) 
are differentially affected by 3 hours of treatment with HMB. Values are mean ± SEM. 
*p≤0.05 compared to 0 µg/mL; §p≤0.05 compared to 0 µg/mL and 50 µg/mL. n = 2. 
 
	124	


























Aimone, J.B., Li, Y., Lee, S.W., Clemenson, G.D., Deng, W., and Gage, F.H. (2014). 
Regulation and function of adult neurogenesis: From genes to cognition. Physiol. Rev. 
94, 991–1026. 
 
Alnaqeeb, M. a, Al Zaid, N.S., and Goldspink, G. (1984). Connective tissue changes 
and physical properties of developing and ageing skeletal muscle. J. Anat. 139 ( Pt 4, 
677–689. 
 
Alway, S.E., Pereira, S.L., Edens, N.K., Hao, Y., and Bennett, B.T. (2013). β-Hydroxy-β-
methylbutyrate (HMB) enhances the proliferation of satellite cells in fast muscles of 
aged rats during recovery from disuse atrophy. Exp. Gerontol. 48, 973–984. 
 
Ammendrup-Johnsen, I., Naito, Y., Craig, A.M., and Takahashi, H. (2015). 
Neurotrophin-3 enhances the synaptic organizing function of TrkC-protein tyrosine 
phosphatase in rat hippocampal neurons. J. Neurosci. 35, 12425–12431. 
 
Aversa, Z., Alamdari, N., Castillero, E., Muscaritoli, M., Fanelli, F.R., and Hasselgren, 
P.O. (2012). β-Hydroxy-β-methylbutyrate (HMB) prevents dexamethasone-induced 
myotube atrophy. Biochem. Biophys. Res. Commun. 423, 739–743. 
 
Barrientos, R.M., Frank, M.G., Watkins, L.R., and Maier, S.F. (2010). Memory 
impairments in healthy aging: Role of aging-induced microglial sensitization. Aging Dis. 
1, 212–231. 
 
Basu, A., Poddar, D., Robinet, P., Smith, J.D., Febbraio, M., Baldwin, W.M., and 
Mazumder, B. (2014). Ribosomal protein L13a deficiency in macrophages promotes 
atherosclerosis by limiting translation control-dependent retardation of inflammation. 
Arterioscler. Thromb. Vasc. Biol. 34, 533–542. 
 
Baxter, J.H., Carlos, J.L., Thurmond, J., Rehani, R.N., Bultman, J., and Frost, D. (2005). 
Dietary toxicity of calcium β-hydroxy-β-methyl butyrate (CaHMB). Food Chem. Toxicol. 
43, 1731–1741. 
 
Bulwa, Z.B., Sharlin, J.A., Clark, P.J., Bhattacharya, T.K., Kilby, C.N., Wang, Y., and 
Rhodes, J.S. (2011). Increased consumption of ethanol and sugar water in mice lacking 
the dopamine D2 long receptor. Alcohol 45, 631–639. 
 
Da Justa Pinheiro, C.H., Gerlinger-Romero, F., Guimarães-Ferreira, L., De Souza, A.L., 
Vitzel, K.F., Nachbar, R.T., Nunes, M.T., and Curi, R. (2012). Metabolic and functional 
effects of beta-hydroxy-beta-methylbutyrate (HMB) supplementation in skeletal muscle. 
Eur. J. Appl. Physiol. 112, 2531–2537. 
 
De Lisio, M., Jensen, T., Sukiennik, R.A., Huntsman, H.D., and Boppart, M.D. (2014). 
Substrate and strain alter the muscle-derived mesenchymal stem cell secretome to 
	126	
promote myogenesis. Stem Cell Res. Ther. 5, 74. 
 
Deutz, N.E.P., Pereira, S.L., Hays, N.P., Oliver, J.S., Edens, N.K., Evans, C.M., and 
Wolfe, R.R. (2013). Effect of β-hydroxy-β-methylbutyrate (HMB) on lean body mass 
during 10 days of bed rest in older adults. Clin. Nutr. 32, 704–712. 
 
Eley, H.L., Russell, S.T., Baxter, J.H., Mukerji, P., Tisdale, M.J., Hl, E., St, R., Jh, B., 
Mukerji, P., and Mj, T. (2007). Signaling pathways initiated by β-hydroxy-β-
methylbutyrate to attenuate the depression of protein synthesis in skeletal muscle in 
response to cachectic stimuli. Am. J. Physiol. 293, 923–931. 
 
Gallagher, P.M., Carrithers, J.A., Godard, M.P., Schulze, K.E., and Trappe, S.W. 
(2000). Beta-hydroxy-beta-methylbutyrate ingestion. Part I: Effects on strength and fat 
free mass. Med. Sci. Sports Exerc. 32, 2109-2115. 
 
Gibbons, T.E., Pence, B.D., Petr, G., Ossyra, J.M., Mach, H.C., Bhattacharya, T.K., 
Perez, S., Martin, S.A., McCusker, R.H., Kelley, K.W., et al. (2014). Voluntary wheel 
running, but not a diet containing (-)-epigallocatechin-3-gallate and β-alanine, improves 
learning, memory and hippocampal neurogenesis in aged mice. Behav. Brain Res. 272, 
131–140. 
 
Goodman, C.A., Mabrey, D.M., Frey, J.W., Miu, M.H., Schmidt, E.K., Pierre, P., and 
Hornberger, T.A. (2011). Novel insights into the regulation of skeletal muscle protein 
synthesis as revealed by a new nonradioactive in vivo technique. FASEB J. 25, 1028–
1039. 
 
Hankosky, E.R., Sherrill, L.K., Ruvola, L.A., Haake, R.M., Kim, T., Hammerslag, L.R., 
Kougias, D.G., Juraska, J.M., and Gulley, J.M. (2016). Effects of β-hydroxy-β-methyl 
butyrate on working memory and cognitive flexibility in an animal model of aging. Nutr. 
Neurosci. 20, DOI 10.1080/1028415X.2016.1145376 Nutritional. 
 
Hebert, L., Weuve, J., Scherr, P., and Evans, D. (2013). Alzheimer disease in the 
United States (2010–2050) estimated using the 2010 census. Neurology 158. 
 
Hunt, L.C., Upadhyay, A., Jazayeri, J.A., Tudor, E.M., and White, J.D. (2013). An anti-
inflammatory role for leukemia inhibitory factor receptor signaling in regenerating 
skeletal muscle. Histochem. Cell Biol. 139, 13–34. 
 
Huntsman, H.D., Zachwieja, N., Zou, K., Ripchik, P., Valero, M.C., De Lisio, M., and 
Boppart, M.D. (2013). Mesenchymal stem cells contribute to vascular growth in skeletal 
muscle in response to eccentric exercise. AJP Hear. Circ. Physiol. 304, H72–H81. 
 
Janssen, I., Shepard, D.S., Katzmarzyk, P.T., and Roubenoff, R. (2004). The healthcare 
costs of sarcopenia in the United States. J. Am. Geriatr. Soc. 52, 80–85. 
 
Jin, K., Sun, Y., Xie, L., Batteur, S., Mao, X.O., Smelick, C., Logvinova, A., and 
	127	
Greenberg, D.A. (2003). Neurogenesis and aging: FGF-2 and HB-EGF restore 
neurogenesis in hippocampus and subventricular zone of aged mice. Aging Cell 2, 175–
183. 
 
Kornasio, R., Riederer, I., Butler-Browne, G., Mouly, V., Uni, Z., and Halevy, O. (2009). 
β-hydroxy-β-methylbutyrate (HMB) stimulates myogenic cell proliferation, differentiation 
and survival via the MAPK/ERK and PI3K/Akt pathways. Biochim. Biophys. Acta - Mol. 
Cell Res. 1793, 755–763. 
 
Kougias, D.G., Nolan, S.O., Koss, W.A., Kim, T., Hankosky, E.R., Gulley, J.M., and 
Juraska, J.M. (2016). Beta-hydroxy-beta-methylbutyrate ameliorates aging effects in the 
dendritic tree of pyramidal neurons in the medial prefrontal cortex of both male and 
female rats. Neurobiol. Aging 40, 78–85. 
 
Kuhn, H.G., Dickinson-Anson, H., and Gage, F.H. (1996). Neurogenesis in the dentate 
gyrus of the adult rat: age-related decrease of neuronal progenitor proliferation. J 
Neurosci 16, 2027–2033. 
 
Lucassen, P.J., Meerlo, P., Naylor, A.S., van Dam, A.M., Dayer, A.G., Fuchs, E., 
Oomen, C.A., and Czéh, B. (2010). Regulation of adult neurogenesis by stress, sleep 
disruption, exercise and inflammation: Implications for depression and antidepressant 
action. Eur. Neuropsychopharmacol. 20, 1–17. 
 
Oliveira, S.L.B., Pillat, M.M., Cheffer, A., Lameu, C., Schwindt, T.T., and Ulrich, H. 
(2013). Functions of neurotrophins and growth factors in neurogenesis and brain repair. 
Cytom. Part A 83 A, 76–89. 
 
Pimentel, G., Rosa, J., Lira, F., Zanchi, N., Ropelle, E., Oyama, L., Oller do 
Nascimento, C., de Mello, M., Tufik, S., and Santos, R. (2011). beta-Hydroxy-beta-
methylbutyrate (HMbeta) supplementation stimulates skeletal muscle hypertrophy in 
rats via the mTOR pathway. Nutr Metab 8, 11. 
 
Rowlands, D.S., and Thomson, J.S. (2009). Effects of beta-hydroxy-beta-methylbutyrate 
supplementation during resistance training on strength, body mass compoition, and 
muscle damage in trained and untrained young men: A meta-analysis. J. Strength 
Cond. Res. 23, 836-846. 
 
Russ (2003). HMB and B-alanine on muscle. Methods Mol Med 89, 385–399. 
 
Salto, R., Vílchez, J.D., Girón, M.D., Cabrera, E., Campos, N., Manzano, M., Rueda, R., 
and López-Pedrosa, J.M. (2015). β-Hydroxy-β-methylbutyrate (HMB) promotes neurite 
outgrowth in Neuro2a cells. PLoS One 10, 1–13. 
 
Santos-Fandila, A., Zafra-Gómez, A., Barranco, A., Navalón, A., Rueda, R., and 
Ramírez, M. (2014). Quantitative determination of b-hydroxymethylbutyrate and leucine 
in culture media and microdialysates from rat brain by UHPLC-tandem mass 
	128	
spectrometry. Anal. Bioanal. Chem. 406, 2863–2872. 
 
Shreeram, S., Ramesh, S., Puthan, J.K., Balakrishnan, G., Subramanian, R., Reddy, 
M.T., and Pereira, S.L. (2016). Age associated decline in the conversion of leucine to β-
Hydroxy-β-Methylbutyrate in rats. Exp. Gerontol. 80, 6–11. 
 
Stout, J.R., Smith-Ryan, A.E., Fukuda, D.H., Kendall, K.L., Moon, J.R., Hoffman, J.R., 
Wilson, J.M., Oliver, J.S., and Mustad, V.A. (2013). Effect of calcium β-hydroxy-β-
methylbutyrate (CaHMB) with and without resistance training in men and women 
65+yrs: A randomized, double-blind pilot trial. Exp. Gerontol. 48, 1303–1310. 
 
Sütterlin, P., Williams, E.J., Chambers, D., Saraf, K., von Schack, D., Reisenberg, M., 
Doherty, P., and Williams, G. (2013). The molecular basis of the cooperation between 
EGF, FGF and eCB receptors in the regulation of neural stem cell function. Mol. Cell. 
Neurosci. 52, 20–30. 
 
Valero, M.C., Huntsman, H.D., Liu, J., Zou, K., and Boppart, M.D. (2012). Eccentric 
exercise facilitates mesenchymal stem cell appearance in skeletal muscle. PLoS One 7. 
 
Vallejo, J., Spence, M., Cheng, A.L., Brotto, L., Edens, N.K., Garvey, S.M., and Brotto, 
M. (2016). Cellular and physiological effects of dietary supplementation with β-hydroxy-
β- methylbutyrate (hmb) and β-alanine in late middle-aged mice. PLoS One 11. 
 
Van Mater, D., Añó, L., Blum, J.M., Webster, M.T., Huang, W.Q., Williams, N., Ma, Y., 
Cardona, D.M., Fan, C.M., and Kirsch, D.G. (2015). Acute tissue injury activates 
satellite cells and promotes sarcoma formation via the HGF/c-MET signaling pathway. 
Cancer Res. 75, 605–614. 
 
von Haehling, S., Morley, J.E., and Anker, S.D. (2010). An overview of sarcopenia: 
Facts and numbers on prevalence and clinical impact. J. Cachexia. Sarcopenia Muscle 
1, 129–133. 
 
Vukovich, M.D., Slater, G., Macchi, M.B., Turner, M.J., Fallon, K., Boston, T., and 
Rathmacher, J. (2001). β-hydroxy-β-methylbutyrate (HMB) kinetics and the influence of 
glucose ingestion in humans. J. Nutr. Biochem. 12, 631–639. 
 
Wilson, J.M., Grant, S.C., Lee, S.-R., Masad, I.S., Park, Y.-M., Henning, P.C., Stout, 
J.R., Loenneke, J.P., Arjmandi, B.H., Panton, L.B., et al. (2012). Beta-hydroxy-beta-
methyl-butyrate blunts negative age-related changes in body composition, functionality 
and myofiber dimensions in rats. J. Int. Soc. Sports Nutr. 9, 18. 
 
Wilson, J.M., Lowery, R.P., Joy, J.M., Andersen, J.C., Wilson, S.M.C., Stout, J.R., 
Duncan, N., Fuller, J.C., Baier, S.M., Naimo, M.A., et al. (2014). The effects of 12 weeks 
of beta-hydroxy-beta-methylbutyrate free acid supplementation on muscle mass, 
strength, and power in resistance-trained individuals: A randomized, double-blind, 
placebo-controlled study. Eur. J. Appl. Physiol. 114, 1217–1227. 
	129	
Wu, H., Xia, Y., Jiang, J., Du, H., Guo, X., Liu, X., Li, C., Huang, G., and Niu, K. (2015). 
Effect of beta-hydroxy-beta-methylbutyrate supplementation on muscle loss in older 
adults: A systematic review and meta-analysis. Arch. Gerontol. Geriatr. 61, 168–175. 
 
Wynne, A.M., Henry, C.J., and Godbout, J.P. (2009). Immune and behavioral 
consequences of microglial reactivity in the aged brain. Integr. Comp. Biol. 49, 254–266. 
 
Zombeck, J.A., Deyoung, E.K., Brzezinska, W.J., and Rhodes, J.S. (2011). Selective 
breeding for increased home cage physical activity in collaborative cross and Hsd:ICR 
mice. Behav. Genet. 41, 571–582. 
 
Zou, K., Huntsman, H.D., Carmen Valero, M., Adams, J., Skelton, J., De Lisio, M., 
Jensen, T., and Boppart, M.D. (2015). Mesenchymal stem cells augment the adaptive 




















COGNITIVE FUNCTION IS PRESERVED IN AGED MICE FOLLOWING LONG-TERM 
β-HYDROXY β-METHYLBUTYRATE (HMB) SUPPLEMENTATION 
 
Prior Work on the Effect of Prolonged Nutritional Supplementation on Cognitive and 
Skeletal Muscle Function 
 
Michael Munroe, Ziad S. Mahmassani, Svyatoslav Dvoretskiy, Justin J. Reid, Benjamin 
















 There is a critical need to develop therapeutic strategies designed to 
concomitantly prevent age-related declines in skeletal muscle and cognitive function. β-
hydroxy β-methylbutyrate (HMB) is a nutritional supplement purported to enhance 
skeletal muscle mass and strength, as well as cognitive function in older adults. 
However, the potential for HMB supplementation to preserve both muscle and brain 
health across the lifespan remains unknown. The purpose of this study was to 
determine the impact of long-term HMB supplementation on muscle function and 
cognitive performance on an active avoidance task in adult and aged mice, as well as to 
provide evidence of a link between vessel-associated pericyte quantity and/or function 
with muscle and cognitive outcomes. Four month-old (Adult/Ad) and 17 month-old 
(Aged/Ag) C57BL/6J mice consumed chow containing 600 mg/kg body weight/day of 
either Ca-HMB (Ad, n=16; Ag, n=17) or Ca-Lactate (Ad, n=16; Ag, n=17) for 6 months. 
HMB did not prevent age-related reductions in muscle mass, strength and coordination 
(Age main effect, p<0.05). The rate of muscle protein synthesis decreased within the 
mitochondrial fraction (Age main effect, p<0.05), and this decline was not prevented 
with HMB supplementation. Despite the lack of change in muscle mass or function, an 
age-dependent reduction in active avoidance learning was significantly attenuated with 
HMB (Age and HMB main effects, p<0.05). Age detrimentally impacted muscle-resident 
pericyte gene expression with no recovery observed with HMB, whereas no changes in 
brain-resident pericyte quantity or function were observed with age or HMB. The 
findings from this study suggest that prolonged HMB supplementation starting in 
adulthood may preserve cognition with age. 
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B.2 Introduction 
 Aging is accompanied by gradual reductions to skeletal muscle structure and 
function that ultimately compromises quality of life and increases risk for disability 
(Carmona and Michan, 2016; Janssen et al., 2004). While progressive loss of skeletal 
muscle mass and strength is commonly observed with aging, severe reductions, 
clinically diagnosed as sarcopenia, are observed in approximately 11-50% of individuals 
at or over the age of 80 years old (von Haehling et al., 2010). The mechanistic basis for 
sarcopenia is not known, yet factors such as inactivity, chronic inflammation, anabolic 
resistance, impaired vascular function, decreased insulin sensitivity, and altered 
proteostasis likely contribute (Cartee et al., 2016). Similarly, impaired executive function 
and episodic memory are observed in older adults (Clarys et al., 2009; Koen and 
Yonelinas, 2014). These losses occur concurrent with reductions to cerebral 
angiogenesis (Brown and Thore, 2011), hippocampal neurogenesis (Seib and Martin-
Villalba, 2015), and microglial quantity (Harry, 2013). Interestingly, a temporal 
relationship between loss of muscle mass and dementia has been documented in 
humans, with progressive and insidious loss of lean muscle mass with age strongly 
correlating with brain atrophy and declines in short-term memory and learning (Burns et 
al., 2010). The link between muscle and brain health in the aged population suggests a 
common mechanism for both sarcopenia and dementia that could be potentially 
addressed with a single therapeutic intervention.   
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 HMB is a leucine metabolite frequently used as a nutritional supplement to 
enhance the beneficial physical adaptations associated with exercise training. Increases 
in lean mass and muscle strength, as well as protection from muscle damage post-
exercise, have been observed with HMB supplementation in young individuals 
beginning a resistance exercise training program (Gallagher et al., 2000; Robinson et 
al., 2014; Wilson et al., 2014). Older adults and individuals with disease also benefit 
from HMB supplementation, as improvements in body composition and strength have 
been observed, particularly after long-term use in conjunction with exercise (Alway et 
al., 2013; Deutz et al., 2013; Molfino et al., 2013; Zanchi et al., 2011). Recent rodent 
studies have expanded the potential benefits of HMB supplementation to include 
maintenance of cognitive function with age. Improvements to working memory and 
visuospatial learning have been observed in aged rats following long-term HMB 
supplementation (Hankosky et al., 2017; Kougias et al., 2017). These results are 
promising, yet the specific mechanisms underlying such benefits are not known. In 
addition, the ability for HMB to concomitantly preserve both muscle mass and cognitive 
function from middle age to end of life has not been tested.  
 Pericytes are contractile cells physically embedded within the vascular basement 
membrane of microvessels, including pre-capillary arterioles, capillaries, and post-
capillary venules (Armulik et al., 2005; Caplan and Correa, 2011). Pericytes 
(CD146+PDGFRβ+/-CD31-CD45-) possess potential for mesodermal differentiation and 
paracrine factor secretion, providing the opportunity to directly and indirectly support 
tissue repair and remodeling (Crisan et al., 2008; Huntsman et al., 2013; Sacchetti et 
al., 2016; Valero et al., 2012). However, loss of pericyte quantity has been observed 
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with aging, diabetic neuropathy, and Alzheimer’s disease (Hall et al., 2014). Based on 
these findings, our lab recently assessed perivascular stem cell (Sca-1+CD45-; CD146+/-
) quantity and function in aged mouse muscle. Whereas quantity remained stable, gene 
expression in isolated cells was markedly altered compared to young controls (Munroe 
et al., 2017). Gene expression of several growth, neurotrophic, and angiogenic factors, 
as well as factors necessary for extracellular matrix (ECM) remodeling, were reduced 
(Munroe et al., 2017). Interestingly, 5.5 weeks of HMB supplementation resulted in the 
partial restoration of perivascular stem cell function in aged mouse muscle, concurrent 
with a significant improvement in muscle strength. The fact that PDGFRβ+ pericyte 
quantity is similarly deficient in the aged mouse hippocampus (Bell et al., 2010) 
suggests that pericytes within the microvascular network throughout the body may be 
vulnerable to aging and possibly represent a common and critical regulator of tissue 
function across the lifespan.  
 The purpose of this study was to (1) determine the extent to which long-term 
HMB supplementation can simultaneously preserve skeletal muscle and cognitive 
function during the progression of aging in a mouse model, and (2) determine the extent 
to which tissue-resident (muscle, whole brain) pericyte quantity and/or function is 
associated with observed outcomes. We hypothesized that HMB supplementation 
initiated at middle age would help preserve skeletal muscle and cognitive function 
across the lifespan, and that alterations in pericyte quantity and/or function would 






 All animal use protocols were approved by the Institutional Animal Care and Use 
Committee at the University of Illinois at Urbana-Champaign, and all NIA guidelines for 
the care and use of animals were followed. Four month-old (Adult, Ad) and 17 month-
old (Aged, Ag) C57BL/6J mice were obtained from Charles River and the National 
Institute on Aging (NIA), respectively. Same sex animals were housed together (2-3 
mice per cage) in a pathogen-free animal room under controlled conditions (12-hour 
light/dark cycle, 25°C). Upon arrival, mice were acclimatized to their new environment 
for seven days and then randomized into four groups based upon body weight (BW): 
Adult+Control (Ad+C, n=16; 8 males, 8 females), Adult+HMB (Ad+H, n=16; 8 males, 8 
females), Aged+Control (Ag+C, n=17; 8 males, 9 females), Aged+HMB (Ag+H, n=17; 8 
males, 9 females). Mice were then fed either an experimental (HMB) or control diet for 
24 weeks.  
 
HMB administration and diet 
 Adult C57BL/6J mice consume approximately 3.5-4.5 g chow/day (for a 25 g 
mouse). Based upon this average chow consumption, Ca-HMB (Abbott Industries, 
Champaign, IL) dosage was calculated to achieve a final daily dose of ~600 mg HMB/kg 
BW/day. An average human dose of HMB is 3 g/day or ~40 mg/kg BW. Using that value 
as the Human Equivalent Dose (HED) (mg/kg BW) (Center for Drug Evaluation and 
Research, 2005), the appropriate dose for mice was determined to be approximately 
500 mg HMB/kg BW/d, an experimental dosage used previously in rodents (Park et al., 
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2013; Wilson et al., 2012). However, as this study was over an extended duration (24 
weeks), the dosage was increased to 600 mg HMB/kg BW/d in order to account for BW 
increases that are typically observed with age. Ca-HMB was mixed into an AIN-93G 
OpenSource Diet (D10012G; Research Diets Inc., New Brunswick, NJ) at a 
concentration of 3.75 g Ca-HMB/kg chow. To account for the addition of calcium in the 
Ca-HMB experimental diet, the control diet was supplemented with an equal 
concentration of Ca-Lactate.  
 
Body weight and grip strength measures  
 Each animal was weighed prior to the experiment and weight was recorded 
weekly thereafter. Four-limb grip strength was measured every two weeks using a 
Digital Grip Strength Meter (Columbus Instruments, Columbus, OH). For grip strength 
measures, mice were placed upon a metal mesh grid connected to a force transducer 
and were allowed to grip with all four limbs. After gripping was confirmed, the 
researcher gently pulled the mouse’s tail posteriorly, parallel to the grid at a constant 
rate until volitional release. Force was recorded (gram-force) for three trials. Weight 
measures obtained immediately after each test was used to express peak grip strength 
relative to body weight (gram force (g)/gram body weight (g)). The same tester 
performed all trials. 
 
Rotarod 
 An automated rotarod unit (AccuRotor RotaRod Tall Unit, 63 cm fall height, 30 
mm diameter rotating dowel; Accuscan, Columbus, OH) was used to assess balance 
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and coordination. Mice were placed on the stationary dowel which then began 
acceleration at a rate of 30 rpm/min. Latency to fall was recorded using a photobeam 
which stopped the timer automatically when the falling mouse broke the photobeam 
plane. Each mouse performed four consecutive trials over three consecutive days. 
 
Active avoidance 
 Each mouse was placed in a Gemini™ Avoidance System (SD Instruments, San 
Diego, CA), and allowed to explore both non-illuminated compartments for 120 
seconds. Following the acclimatization period, the unoccupied compartment was 
illuminated for five seconds (conditioned stimuli, CS) followed by a five second 
footshock in the non-illuminated/occupied compartment (0.5 mA) (unconditioned stimuli, 
US). Three possible outcomes were recorded. The mouse could avoid the US by 
moving to the illuminated compartment during the CS (“Avoidance Response”). The 
mouse could escape the US by moving to the illuminated compartment during the US, 
ending the trial (“Escape Response”). If the mouse failed to avoid or escape the US, a 
“Non-Response” was recorded. Once the mouse avoided, escaped, or failed to 
respond, there was a 10 second inter-trial interval before the next trial. Each mouse 
completed 50 consecutive trials daily for five consecutive days for a total of 250 trials. 
 
Heavy water (2H2O) incorporation 
 Heavy water labeling is a safe and reliable method for determining protein 
synthesis rates for different protein fractions such as, myofibrillar, cytoplasmic, and 
mitochondrial fractions within muscle tissue (Busch et al., 2006; Busch et al., 2007). 
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Heavy water administration began 20 weeks after the start of supplementation. To bring 
mice up to 5% body water enrichment (based on 60% body weight as water), 99% 2H2O 
(with 0.9% w/v NaCl and sterilized via filtration) (Sigma Aldrich) was injected 




 After 24 weeks, mice were fully anesthetized using isoflurane and blood was 
collected via cardiac puncture. Gastrocnemius-soleus muscle complexes were then 
excised and muscle weight was recorded. One complex was immersed in ice-cold 1x 
PBS plus penicillin/streptomycin and used for pericyte isolation. The other muscle 
complex was snap frozen in liquid nitrogen to be used for protein synthesis analysis. 
The brain was then dissected and immersed in ice-cold MEM with HEPES modification 
(Sigma Aldrich) and used for pericyte isolation. Collected blood was allowed to clot in a 
2.0 mL eppendorf tube for 30 minutes at room temperature then centrifuged at 1200 x g 
for ten minutes at 4°C. Serum supernatant was transferred to a new 1.5 mL eppendorf 
tube and stored at -80°C.  
 
Pericyte isolations and FACS 
 For the isolation of CD146+CD45-CD31- pericytes from skeletal muscle, 
dissected muscle tissue was minced and enzymatically digested for approximately 45 
minutes at 37°C. The enzyme solution consisted of 250 U/mL collagenase Type 2 
(Worthington-Biochemical Corp., Lakewood, NJ), 2 U/mL neutral protease (Dispase) 
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(Worthington-Biochemical Corp.), 60 U/mL DNase (Sigma Aldrich), 5 mM CaCl2 in 1x 
Hank’s balanced salt solution. Enzymatic reactions were inhibited with a 20% FBS in 1x 
PBS solution with 1mM EDTA, and then the cell solution was filtered, first using a 70 µm 
then a 40 µm filter. The filtered cell suspension was then blocked with anti-mouse 
CD16/CD32 antibody (eBioscience, San Diego, CA) to prevent Fc-mediated nonspecific 
binding. After blocking, cells were incubated with a mix of monoclonal anti-mouse 
antibodies (eBioscience), CD146-phyocerythrin (PE) (1:50), CD45-fluorescein 
isothiocyanate (FITC) (1:100), and CD31-FITC (1:100), for 1 hour in filtered 2% FBS in 
1x PBS at 4°C. Cell suspension was then filtered through a 40 µm filter and kept on ice 
for fluorescence-activated cell sorting (FACS).  
 For the isolation of PDGFRβ+CD45-CD31- pericytes from whole brain tissue, cell 
isolation procedures were adapted from Boroujerdi et al. (2014). Excised brains were 
minced and the tissue slurry was transferred to a 15 mL tube and centrifuged at 300 x g 
for five minutes. The tissue slurry was then resuspended in 5 mL of enzyme solution (20 
U/mL papain from papaya latex (Worthington-Biochemical Corp.), 1mM L-cysteine, 0.5 
mM EDTA, and 2.5 U/µL DNase I (Worthington-Biochemical Corp.) for approximately 60 
minutes at 37°C. The slurry was transferred to a 50 mL tube and titurated x10 with a 19-
gauge needle then x10 with a 21-gauge needle to disrupt microvessels. An equal 
volume of 20% BSA inhibition media was added and cells were filtered through a 70 µm 
and a 40 µm filter. Cells were then blocked as described above and resuspended in a 
mix of monoclonal anti-mouse antibodies (eBioscience), PDGFRβ/CD140b-
phyocerythrin (PE) (1:50), CD45-fluorescein isothiocyanate (FITC) (1:100), and CD31-
FITC (1:100), for 1 hour in filtered 2% FBS in 1x PBS at 4°C. Cell suspension was then 
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filtered through a 40 µm and kept on ice for FACS. 
 FACS was performed using a BD FACS Aria II sorter at the University of Illinois 
at Urbana-Champaign Roy J. Carver Biotechnology Center (CBC) (Urbana, IL). Tissue-
specific negative and single-stain controls were used to established appropriate gating 
for FACS, and cells were collected in 2% FBS in 1x PBS solution. Post-sorting, cells 
were immediately centrifuged at 450 x g for five minutes, lysed in Buffer RLT (Qiagen, 
Valencia, CA) and snap frozen in liquid nitrogen to be analyzed for relative mRNA 
expression. Lysed cells were stored at -80°C until analysis. 
 
Protein fractionation 
 For protein isolation, skeletal muscle was fractionated according to our previously 
published procedures (Drake et al., 2013; Drake et al., 2014; Miller et al., 2012; Miller et 
al., 2013). The muscle complex was homogenized 1:10 in isolation buffer (100 mM KCl, 
40 mM Tris HCl, 10 mM Tris Base, 5 mM MgCl2, 1 mM EDTA, 1 mM ATP, pH = 7.5) 
with phosphatase and protease inhibitors (HALT) (Thermo Scientific, Rockford, IL) using 
a bead homogenizer (Next Advance Inc., Averill Park, NY). After homogenization, 
subcellular fractions were isolated via differential centrifugation as previously described 
(Drake et al., 2013; Drake et al., 2014; Miller et al., 2012; Miller et al., 2013).  Once 
protein pellets were isolated and purified, 250 µL 1 M NaOH was added and pellets 
were incubated for 15 min at 50 °C will slowly mixing. For DNA analysis, DNA was 
extracted from ~20 mg of tissue or bone marrow suspension using a QiAamp DNA mini 
kit (Qiagen). Protein was hydrolyzed by incubation for 24 h at 120 °C in 6N HCl.  The 
pentafluorobenzyl-N,N-di(pentafluorobenzyl) derivative of alanine was analyzed on an 
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Agilent 7890A GC coupled to an Agilent 5975C MS as previously described (Drake et 
al., 2013; Drake et al., 2014; Miller et al., 2012; Miller et al., 2013). 
 To determine body water enrichment, 125 µL of plasma was placed into the inner 
well of o-ring screw cap and inverted on heating block overnight. 2 µL of 10 M NaOH 
and 20 µL of acetone were added to all samples and to 20 µL 0–20% D2O standards 
and then capped immediately. Samples were vortexed at low speed and left at room 
temperature overnight. Extraction was performed by the addition of 200 µL hexane. The 
organic layer was transferred through anhydrous Na2SO4 into GC vials and analyzed via 
EI mode.   
 The newly synthesized fraction of proteins was calculated from the product 
enrichment divided by the true precursor enrichment using plasma analyzed for D2O 
enrichment and adjusted according to mass isotopomer distribution analysis (MIDA) 
(Drake et al., 2013; Drake et al., 2014). The fraction new was divided by time and 
expressed as fractional synthesis rates (FSR: %/day). 
Serum 4-HNE analysis 
 Serum 4-HNE, a marker of lipid peroxidation and oxidative stress, was measured 
in duplicate using a commercially available ELISA kit (Cell Biolabs OxiSelectTM HNE 
Adduct ELISA kit, San Diego, CA). Intensity of color was measured at 450 nanometers 
using a Synergy H1 Hybrid Multi-Mode Microplate Reader (BioTek). Protein 
concentrations were quantified using a standard curve (provided by manufacturer). 
 
RNA isolation, cDNA synthesis, and high throughput microfluidic qPCR using Fluidigm 
Biomark™ HD 
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 RNA was extracted from cell lysates using RNeasy Micro Kit (Qiagen), following 
the manufacturer’s instruction. Quantity of isolated RNA was assessed in duplicate on a 
Take-3 application plate using a Synergy H1 Hybrid Multi-Mode Microplate Reader 
(BioTek, Winooski, VT). Starting RNA concentration of 25 ng was used to perform 
reverse transcription via the High Capacity cDNA Reverse Transcription Kit (Life 
Technologies, Grand Island, NY) per manufacturer’s instructions.  
 High throughput microfluidic quantitative PCR (qPCR) of synthesized cDNA was 
ran on a 96x96 Dynamic Array Integrated Fluidic Circuit (IFC) (Fluidigm, San Francisco, 
CA) by the Functional Genomics Unit at the CBC (Urbana, IL). This qPCR system 
results in a more accurate and repeatable analysis of multiple genes within multiple 
samples (up to 96 genes analyzed in up to 96 samples). Diluted cDNA samples and 
primers were mixed together on a Dynamic Array Chip using the IFC system. The chip 
was then loaded into the Fluidigm BiomarkTM HD for qPCR analysis. Glyceraldehyde 3-
phosphate dehydrogenase (GAPDH) was used as the housekeeping gene, and relative 
mRNA expression was expressed relative to the Ad+C group using the ΔΔCt method. 
Primer information and gene expression assay ID numbers are provided in 
Supplementary Table B.1. 
 
Statistical analysis 
 All data is presented as mean ± SEM. Two-way ANOVA was performed to 
determine HMB x Age interaction effects and main effects of Age or HMB followed by 
least significant difference (LSD) post-hoc analysis when appropriate. Body weight and 
grip strength as well as daily rotarod and active avoidance data was analyzed using 
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repeated measures ANOVA followed by LSD post-hoc analysis. All statistical analyses 
were completed using SPSS Ver. 24 (IBM, Chicago, IL). Differences were considered 











































Long-term HMB supplementation does not alter age-related changes to skeletal muscle 
weight or function 
 The experimental design for determining the impact of 24 weeks of HMB 
supplementation on adult and aged skeletal muscle and cognitive function is outlined in 
Figure 1A. Ca-HMB and Ca-Lactate was estimated weekly. Chow quantity was weighed 
at the beginning and end of each week. Based upon the amount of chow consumed 
during the week, supplement intake was calculated. No differences in average daily 
supplement consumption were observed between groups over the 24 week period 
(Ad+C, 380.0 ± 13.3; Ad+H, 391.2 ± 10.8; Ag+C, 388.5 ± 22.0; Ag+H, 367.4 ± 12.2 
mg/kg BW/day). After 24 weeks of supplementation, both body weight and absolute 
gastrocnemius-soleus muscle weight were significantly reduced with age (Age main 
effect, p=0.01) (Figure 1B and 1C), while relative muscle weight remained unchanged 
between groups (Figure 1D).  
  Prior to supplementation, relative peak grip strength was lower in the Aged 
groups compared to the Adult groups (Age main effect, p=0.01). After 24 weeks, 
strength had decreased significantly within each group (Time main effect, p<0.001), but 
no strength differences between groups were noted post-supplementation (Figure 1E). 
To assess muscular coordination and balance, mice underwent three days of Rotarod 
testing, with improved performance being measured by an increase in latency to fall 
(seconds). Mice increased their time on the Rotarod each day (Day main effect, 
p<0.001). A significant Day x Age interaction effect (p<0.001) was observed attributable 
to the increased latency in the Adult groups compared to the Aged groups on Days 2 
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and 3 collapsed across diet (Figure 1F). The average latency to fall during the three-day 
testing period was significantly less in the Aged groups compared to Adult groups (Age 
main effect, p=0.01) (Figure 1G). 
 Skeletal muscle protein synthesis was measured using deuterium oxide (2H2O) 
labeling with separate protein fractions analyzed. Mixed and cytoplasmic fractional 
synthetic rates (FSR, %/day) trended to increase with age regardless of 
supplementation (Mixed, p=0.06; Cytoplasmic, p=0.09) (Figure 1H and 1I). Aged mice 
had significantly reduced mitochondrial FSR compared to Adult mice (Age main effect, 
p=0.01) (Figure 1J). In addition, a trend for an Age x HMB interaction effect (p=0.06) 
was detected as HMB supplementation increased FSR (not significant) in Aged, but not 
Adult mice. Mitochondrial content and activity within cells contributes to reactive oxygen 
species (ROS) production, with 4-hydroxynonenal (4-HNE) being a major byproduct of 
lipid peroxidation and subsequent oxidative stress (Chapple et al., 2013). Given the 
observed alterations to mitochondrial protein synthesis, we assessed serum 4-HNE 
content using ELISA. While not statistically significant, a trend for an Age x HMB 
interaction effect (p=0.07) was observed post-supplementation (Ad+C, 25.12 ± 1.85; 
Ad+H, 21.93 ± 0.80; Ag+C, 21.65 ± 1.36; Ag+H, 24.04 ± 1.67 µg/mL). 
 
Age-related reductions in active avoidance learning are attenuated with HMB 
supplementation 
 Learning performance on the active avoidance test was measured in response to 
long-term HMB supplementation. The total number of active avoidances recorded per 
day is presented in Figure 2A. A main effect of age was detected, with Adult mice 
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displaying an overall greater number of active avoidances than Aged mice collapsed 
across days and supplementation (Age main effect, p<0.001).  A significant main effect 
of day was also observed (Day main effect, p<0.001) suggesting all groups successfully 
learned the task, as indicated by the increasing number of active avoidances collapsed 
across groups (Day main effect, p<0.001). Additionally, a significant Day x Age 
interaction effect was observed (p=0.01) driven by a progressively greater difference in 
the number of successful active avoidances between Aged and Adult mice each day.  In 
addition, a trend for an Age x HMB interaction effect was noted (p=0.08). Specifically, 
HMB increased the number of active avoidances achieved in Aged but not Adult mice 
on Day 4 (p=0.15) and 5 (p=0.04). On Day 5 alone, both significant Age (p=0.001) and 
HMB (p=0.04) main effects were detected with Adult mice successfully avoiding more 
foot shocks than Aged mice, and HMB supplementation resulting in an increase in the 
number of avoidances achieved compared to controls (Figure 2B). 
 Figure 2C represents the number of escape responses recorded over the five 
days of active avoidance testing. Both Adult and Aged mice had progressively fewer 
escape responses over the five days (Day main effect, p<0.001) with Adult mice 
recording fewer escapes overall throughout testing (Age main effect, p<0.001). A 
significant Day x HMB interaction effect (p=0.001) was detected driven by significantly 
more escapes in the Ad+C group on Day 1 and 2 and significantly fewer escapes in the 
Ag+C group on Day 4 and 5. In addition, a trend for an Age x HMB interaction effect 
was observed (p=0.06) with HMB supplementation resulting in a significant reduction in 
the number of escapes in Aged but not Adult mice on Day 5 (p=0.04). 
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 The number of non-responses demonstrated significant Age (p=0.04) and HMB 
(p=0.04) main effects on Day 1 and 2 (Figure 2D). In addition, a significant Day main 
effect (p<0.001) was observed over the five days of testing with fewer non-responses 
recorded daily. A significant Day x Age x HMB interaction effect (p=0.003) was detected 
driven by the Ad+C group recording significantly more non-responses on Day 1 and 2 
compared to the other three groups. Importantly, on Day 5, no non-responses were 
recorded for any group. 
 Escape latency (seconds) is the time between the onset of the US (foot shock) 
and a successful escape, which is presented in Figure 2E. A significant Day main effect 
(p<0.001) was observed indicating all groups improved in their response time to the US. 
A significant Day x Age interaction effect (p=0.01) was noted due to a shorter response 
latency in the Adult groups on Day 3-5 compared to Aged counterparts. 
 
Skeletal muscle-derived pericyte myogenic proliferation and differentiation factor gene 
expression is altered with age and HMB supplementation 
 Post-supplementation, CD146+CD31-CD45- pericyte quantity was not statistically 
different between groups (Ad+C, 52.0 ± 11.0%; Ad+H, 53.5 ± 8.7%; Ag+C, 43.3 ± 9.9%; 
Ag+H, 45.5 ± 9.8%) (p=0.41). Pericyte gene expression, however, demonstrated 
specific alterations attributable to age or supplementation (Table 1). Specifically, factors 
related to myogenesis were differentially altered by age and HMB. Paired box 7 (Pax7), 
myogenic factor 5 (Myf5), and myogenic differentiation 1 (Myod) expression was 
significantly reduced with age (Age main effect, p<0.05) with Myf5 expression reduced 
with HMB supplementation as well (HMB main effect, p=0.03). A significant HMB main 
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effect was observed for relative myogenin (Myog) expression (p=0.05), which was 
significantly elevated in the Ag+C group only. No significant effect of age or HMB was 
observed for any growth or neurotrophic factors analyzed. Select extracellular matrix 
remodeling and inflammatory/oxidative stress factors were impacted by age, but not 
HMB supplementation. Matrix metallopeptidase 14 (Mmp14), tissue inhibitor of 
metallopeptidase 1 (Timp1), and angiogenin (Ang) mRNA expression was significantly 
reduced with age (Age main effect, p<0.05). Similarly, metallothionein 2 (Mt2) and heme 
oxygenase 1 (Hmox1) mRNA expression was reduced in Aged mice (Age main effect, 
p<0.05). While not statistically significant, tumor necrosis factor alpha (Tnfa) expression 
appeared to increase with age and decrease with HMB supplementation (p=0.06). 
 
Brain-derived pericyte gene expression is largely unaffected by age or HMB after 24 
weeks of HMB supplementation 
 PDGFRβ+CD31-CD45- pericyte quantity isolated from whole brain tissue was not 
statistically different between groups (Ad+C, 6.5 ± 3.3%; Ad+H, 8.6 ± 3.4%; Ag+C, 6.4 ± 
1.9%; Ag+H, 3.6 ± 1.7%) (p=0.35), and minimal functional changes were observed in 
response to age or supplementation (Table 2). Leukemia inhibitory factor (Lif) mRNA 
expression was significantly increased with age (Age main effect, p=0.03), while a 
significant Age x HMB interaction effect was observed for hepatocyte growth factor 
(Hgf) expression (p=0.03). No effect of age or HMB was observed for any neurotrophic 
factor analyzed. Early B-cell factor 2 (Ebf2) has been shown to contribute to the normal 
development of the cerebellar cortex (Hoxha et al., 2013), and had significantly 
increased mRNA expression with age (p=0.04).  The extracellular matrix remodeling 
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proteins, laminin-α2 (Lama2) and Ang, demonstrated increased relative mRNA 
expression with age (p<0.05), but neither was affected by HMB supplementation. In 
contrast, toll-like receptor 3 (Tlr3), part of the receptor family of the innate immune 
system, had significantly reduced expression with HMB (p=0.03). Metabolic regulatory 
factors, zinc finger protein 423 (Zfp423) and peroxisome proliferator-activated receptor 
gamma co-activator 1 alpha (Ppargc1/Pgc1a) were differentially altered by age and 
supplementation. Zfp423 expression was significantly reduced with HMB 
supplementation (p=0.03), while Ppargc1 expression demonstrated a significant Age x 
HMB interaction effect (p=0.03) attributable to altered expression with supplementation 















B.5 Discussion  
 The purpose of this study was to evaluate the impact of long-term HMB 
supplementation on the simultaneous preservation of skeletal muscle and cognitive 
function from middle age to late life in mice. While HMB supplementation did not 
effectively maintain absolute muscle weight, strength, or coordination during the 
progression of aging, supplementation demonstrated strong capacity to preserve active 
avoidance learning. Our previous work demonstrated that age can markedly reduce 
muscle-resident perivascular cell function, and that acute HMB supplementation can 
partially recover selective release of regenerative growth factors (Munroe et al., 2017). 
In the current study, a similar decline was noted in muscle-derived pericyte function, yet 
no recovery was noted with HMB supplementation.  Brain-derived pericyte function was 
largely unaffected by age or HMB. However, brain-derived pericytes were isolated 
following whole brain dissection, and the changes in gene expression may not 
accurately reflect pericyte function within regions necessary for active avoidance 
memory and learning (hippocampus, prefrontal cortex) (Moscarello and LeDoux, 2013; 
Wang et al., 2015). Overall, these data suggest that long-term HMB supplementation 
preserves certain aspects of cognitive function in aged mice, and future studies are 
necessary to elucidate the mechanistic basis for this observation.  
 
HMB fails to enhance skeletal muscle mass or function in either adult or aged sedentary 
mice 
 The majority of HMB supplementation studies demonstrate beneficial 
contributions to skeletal muscle mass and strength during resistance training, cachexia, 
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or atrophy (Aversa et al., 2011; Deutz et al., 2013; Wilson et al., 2014), whereas few 
studies report the impact of HMB on sedentary skeletal muscle (Alway et al., 2013; 
Gerlinger-Romero et al,. 2011; Munroe et al., 2017). When administered in conjunction 
with exercise or disease conditions, HMB can positively impact muscle strength and 
health (Holeček, 2017; Rowlands and Thomson, 2009), however in the absence of 
stimuli, muscle function appears to be unaffected or equivocal (Alway et al., 2013; Kim 
et al., 2012; Russ et al., 2015; Da Justa Pinheiro et al., 2012; Vallejo et al., 2016). 
Consistent with these reports, HMB supplementation in the current study did not 
significantly alter body weight, muscle weight, or muscle function in sedentary mice 
when administered during the progression of aging. We previously demonstrated 
improvement in muscle strength with short-term (5.5 weeks) HMB supplementation in 
aged mice, yet the degrees of decline and recovery were minimal and did not occur until 
the last week of administration. We speculate that significant injury, atrophy, and/or 
inflammation may be necessary for HMB supplementation to exhibit a robust impact on 
muscle structure and function in the context of aging, conditions that are rare in a 
mouse model of uncomplicated aging.     
 
Skeletal muscle protein synthesis rates are slightly altered with age but not HMB  
 Maintenance of muscle mass is achieved through a balance between muscle 
protein synthesis and breakdown. Muscle protein balance becomes dysfunctional with 
age, in part due to aged muscle’s inability to increase postprandial protein synthesis 
rates (Burd et al., 2013). Only two studies have attempted to determine the impact of 
HMB on muscle protein balance in vivo, and both report increases in protein synthesis 
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immediately after administering a bolus of HMB (Kao et al., 2016; Wilkinson et al., 
2013). To our knowledge, this is the first study to investigate fractional protein synthesis 
rates after long-term HMB supplementation in either adult or aged muscle. There was a 
trend toward increased myofibrillar (p=0.06) and cytoplasmic (p=0.09) protein synthesis 
in Aged versus Adult mice, and a significant decrease in mitochondrial protein synthesis 
in Aged versus Adult mice. These changes are potentially related to the aging process. 
Specific to mitochondria, Standley et al. (2017) recently observed no impact of HMB 
supplementation on mitochondrial content following 10-days of bed rest in aged 
humans. Although content did not change in this study, it is not possible to determine 
changes in turnover and remodeling from content alone. In the current study, there was 
a trend for HMB to increase mitochondrial protein synthesis in Aged mice (p=0.06). This 
potential improvement is notable in that changes in mitochondrial biogenesis may be 
related to alterations to cognitive function (Swerdlow, 2017). It is also important to note 
that our measurements were made in the last 4 weeks of supplementation, so it is 
possible that there was increased turnover during the initial 20 weeks that remodeled 
mitochondria to a “healthier” state prior to our period of measure. Additional studies are 
necessary to address the interaction between HMB, mitochondrial synthesis and 
oxidative metabolism.  
 
Decline in active avoidance learning is attenuated with long-tem HMB supplementation 
in aged mice 
 Active avoidance is a form of operant-based conditioning designed to quantify 
the rodent’s ability to perform the appropriate action (move from one side of the 
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apparatus to the other towards the light cue), in response to presentation of a stimulus 
(light cue) in order to avoid a negative outcome (shock). Our finding that the aging-
related decline active avoidance performance is partially rescued with HMB treatment in 
aged mice is consistent with a recent study in rats, which found that long-term HMB 
supplementation maintains cognitive flexibility and dynamic learning on a different 
operant task (Hankosky et al., 2017). The explanation for the improved performance in 
aged rodents is not clear.  In our study, it could be related to the observation that HMB 
treated animals displayed more escapes than no-responses during the early days of 
training than the control treated.  A greater number of escapes might indicate the mice 
were in the process of learning the rule for avoidance and at least were responding.  
However, why HMB caused mice to make more escapes, and how it enhanced learning 
in the aged mice is unclear at this time.  Regardless, the current findings indicate that 
HMB supplementation throughout adulthood and into later life may prevent certain 
aspects of cognitive decline. 
 
CD146+Lin- skeletal muscle pericytes exhibit specific changes to myogenic factor gene 
expression with age and HMB supplementation 
 We have previously observed the dual effect of age and HMB on perivascular 
stem cell (Sca-1+CD45-) function in muscle, including HMB’s ability to attenuate age-
related declines in expression of factors associated with satellite cell activation and 
myofiber repair (Hgf, Lif) (Munroe et al., 2017). In the current study, alterations in gene 
expression were observed with age, yet the changes were less robust and did not 
include regenerative growth factors. One possible explanation for the discrepancy 
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between our prior and current studies is that we used a new cell marker to isolate 
muscle-resident pericytes. CD146 is a well-established pericyte marker, and isolation 
based on this marker, with the elimination of CD45+ hematopoietic and CD31+ 
endothelial cells during FACS, ensures the specific retrieval of vascular-associated 
mural cells (designated CD146+Lin-). We have verified that a percentage of CD146+Lin- 
pericytes obtained from sorting express Sca-1, yet Sca-1+CD45- and CD146+Lin- 
pericytes are not equivalent and include slightly different cell populations. Despite this 
limitation, age-related decreases in gene expression were observed in CD146+Lin- 
pericytes, including myogenic proliferation/activation factors (Pax7, Myf5, Myod) and 
factors necessary for extracellular matrix remodeling and angiogenesis (Mmp14, Timp1, 
Ang). HMB supplementation reversed Myf5 and decreased Myog gene expression, with 
no impact on any other factors. We speculate that pericytes isolated from aged muscle 
might have a reduced capacity for self-renewal, and an increased capacity for terminal 
differentiation, and HMB can prevent these changes. Finally, it is important to note that 
Tnfa gene expression trended to increase with age (highly significant in our previous 
study), and a trend toward a decrease was observed with HMB. This would also 
suggest that pericyte dysfunction may contribute to an elevation in muscle inflammation 
with aging, and that some of the benefits of long-term HMB may occur via modification 
of this response. 
 
Brain-derived PDGFRβ+Lin- pericyte gene expression is minimally affected following 
long-term HMB supplementation in adult and aged mice 
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 This study is the first to evaluate the impact of age and HMB on whole brain 
pericyte gene expression. We chose to isolate pericytes using the cell surface marker 
PDGFRβ to remain consistent with prior studies that have reported a decrease in 
pericyte quantity in the mouse hippocampus with age (Bell et al., 2010). In the current 
study, PDGFRβ+Lin- pericyte quantity was highly variable and gene expression was 
largely unaffected by age or HMB. Gene expression of factors associated with 
angiogenesis (Ang) (Li and Hu, 2012) and cerebellar development (Ebf2) (Hoxha et al., 
2013) was altered with age, while other ECM remodeling and neurotrophic factors 
remained unaltered. A possible explanation for these inconsistencies could be due to 
regional differences in pericyte quantity and function, such as the hippocampus or 
prefrontal cortex. As different sections of the brain help to regulate various physiological 
processes, it follows that cell types from these regions, including pericytes, might 
possess different functional capabilities. Future research should focus on evaluating 
region-specific pericyte function changes with age. 
 
B.6 Conclusion 
 In conclusion, the findings from this study suggest that initiation of HMB 
supplementation at mid-life can provide benefits to cognitive performance in the years 
that follow. Pericyte quantity and function as assessed following isolation from whole 
brain tissue does not appear to provide the basis for this advantage. However, future 
research is needed to evaluate whether pericytes from specific regions of the brain (e.g. 
hippocampus, prefrontal cortex) confer positive changes in cognitive performance 
observed in aged mice supplemented with HMB.  
	156	
B.7 Acknowledgements 
 The authors would like to thank Alejandro Barranco and Christopher Moulton 
(Abbott Nutrition) for their advice and guidance as well as providing the Ca-HMB for this 
study. We also want to acknowledge undergraduate research assistants Ryan Brander 
and Alay Parikh for their help with data collection, and Fredrick Peelor, Jamie Laurin, 
and Gaia Bublitz with their help with tissue processing and isotope analysis. We would 
like to thank Dr. Mark Band and the Functional Genomics Unit at the Roy J. Carver 
Biotechnology Center, for their assistance with the high throughput microfluidic qPCR. 
Finally, we appreciate Dr. Barbara Pilas and the Flow Cytometry Center at the Roy J. 
Carver Biotechnology Center for their assistance with FACS. This work was supported 
by a grant from Abbott Nutrition through the Center for Nutrition, Learning, and Memory 
at the University of Illinois at Urbana-Champaign (Abbott CNLM ZAA68 to MDB and 


























Figure B.1. Age-related changes to skeletal muscle mass and function are 
unaffected by long-term HMB supplementation. Experimental design for 
supplementation and behavioral testing (A). Body weight and gastrocnemius-soleus 
muscle weight was reduced with age after 24 weeks of supplementation (B, C), while 
relative muscle weight was not different between groups (D). Relative peak grip strength 
was not different between groups following supplementation (E). Coordination and 
balance was reduced with age, but not affected by HMB supplementation (F, G). Mixed 
(H) and cytoplasmic (I) fractional synthetic rate (FSR) was unaltered by age or HMB, 
with a significant reduction to mitochondrial FSR (J) observed. Values are mean ± SEM. 
*p < 0.05, Age main effect; ^p < 0.05, Time main effect; †p < 0.05, Day main effect. n = 












































Figure B.2. Cognitive function is preserved in aged mice supplemented with HMB. 
The number of successful avoidances improved daily with greater improvements 
observed in Adult mice (A). On Day 5, HMB supplementation attenuated age-related 
reductions to avoidance responses (B). The number of escape responses decreased 
over the testing period with Aged mice completing more escapes overall (C). The 
number of non-responses was overall reduced daily, and no non-responses were 
recorded on Day 5 for any group (D). The escape latency decreased daily with a greater 
reduction observed in Adult compared to Aged mice (E). Values are mean ± SEM. *p < 






























































Table B.1. Impact of age and HMB supplementation on skeletal muscle pericyte 
gene expression. Gene expression values are presented as mean ± SEM. Age and 










































Table B.2. Impact of age and HMB supplementation on brain pericyte gene 
expression. Gene expression values are presented as mean ± SEM. Age and HMB 
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